{
  "questions": [
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/39555889"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39555889",
          "text": "RankMHC: Learning to Rank Class-I Peptide-MHC Structural Models.. The binding of peptides to class-I Major Histocompability Complex (MHC) receptors and their subsequent recognition downstream by T-cell receptors are crucial processes for most mult...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.2638596296310425,
          "rerank_position": 1
        }
      ],
      "id": "67d74cde18b1e36f2e00003c",
      "type": "summary",
      "body": "Describe RankMHC"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/35977725",
        "http://www.ncbi.nlm.nih.gov/pubmed/31365134",
        "http://www.ncbi.nlm.nih.gov/pubmed/29154906",
        "http://www.ncbi.nlm.nih.gov/pubmed/31538196",
        "http://www.ncbi.nlm.nih.gov/pubmed/37069528",
        "http://www.ncbi.nlm.nih.gov/pubmed/33955776",
        "http://www.ncbi.nlm.nih.gov/pubmed/10322219",
        "http://www.ncbi.nlm.nih.gov/pubmed/9342339",
        "http://www.ncbi.nlm.nih.gov/pubmed/32716929",
        "http://www.ncbi.nlm.nih.gov/pubmed/24354965"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35977725",
          "text": "Anaplastic ganglioglioma-A diagnosis comprising several distinct tumour types.. AIMS: Anaplastic ganglioglioma is a rare tumour, and diagnosis has been based on histological criteria. The 5th edition of the World Health Organization Classification...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.3859790563583374,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31365134",
          "text": "Revisiting the classification of adhesion GPCRs.. G protein-coupled receptors (GPCRs) are encoded by over 800 genes in the human genome. Motivated by different scientific rationales, the two classification systems that are mainly in use, the ABC a...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.2993395924568176,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29154906",
          "text": "Increase in taxonomic assignment efficiency of viral reads in metagenomic studies.. Metagenomics studies have revolutionized the field of biology by revealing the presence of many previously unisolated and uncultured micro-organisms. However, one ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.2685198187828064,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31538196",
          "text": "Hunting the Snark: the flawed search for mythical Jurassic angiosperms.. Several recent palaeobotanical studies claim to have found and described pre-Cretaceous angiosperm macrofossils. With rare exceptions, these papers fail to define a flower, d...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.2455098032951355,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37069528",
          "text": "Multimodal ultrasound features of breast cancers: correlation with molecular subtypes.. OBJECTIVES: To investigate whether multimodal intratumour and peritumour ultrasound features correlate with specific breast cancer molecular subtypes. METHODS:...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.24300655722618103,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33955776",
          "text": "Annual Screening Mammography Associated With Lower Stage Breast Cancer Compared With Biennial Screening.. OBJECTIVE. The purpose of this study was to compare breast cancer characteristics and treatment regimens among women undergoing annual versus...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.2296096384525299,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10322219",
          "text": "Predicting structures for genome proteins.. Assigning three-dimensional protein folds to genome sequences is essential to understanding protein function. Although experimental three-dimensional structures are currently available for only a very sm...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.22159343957901,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9342339",
          "text": "Assigning folds to the proteins encoded by the genome of Mycoplasma genitalium.. A crucial step in exploiting the information inherent in genome sequences is to assign to each protein sequence its three-dimensional fold and biological function. He...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.22122521698474884,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32716929",
          "text": "Entrofy your cohort: A transparent method for diverse cohort selection.. Selecting a cohort from a set of candidates is a common task within and beyond academia. Admitting students, awarding grants, and choosing speakers for a conference are situa...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.1958867609500885,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24354965",
          "text": "Specific cancer rates may differ in patients with hereditary haemorrhagic telangiectasia compared to controls.. BACKGROUND: Hereditary haemorrhagic telangiectasia (HHT) is inherited as an autosomal dominant trait, affects ~1 in 5,000, and causes m...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.19100916385650635,
          "rerank_position": 10
        }
      ],
      "id": "65f7741fc4010b4d78000027",
      "type": "factoid",
      "body": "What proportion of colorectal cancer cases are not assignable to any of the consensus molecular subtype (CMS) groups?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/12166544",
        "http://www.ncbi.nlm.nih.gov/pubmed/10730545",
        "http://www.ncbi.nlm.nih.gov/pubmed/12688198",
        "http://www.ncbi.nlm.nih.gov/pubmed/17305582",
        "http://www.ncbi.nlm.nih.gov/pubmed/16526979",
        "http://www.ncbi.nlm.nih.gov/pubmed/15095746",
        "http://www.ncbi.nlm.nih.gov/pubmed/30385603",
        "http://www.ncbi.nlm.nih.gov/pubmed/18673225",
        "http://www.ncbi.nlm.nih.gov/pubmed/16042713",
        "http://www.ncbi.nlm.nih.gov/pubmed/18998474"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12166544",
          "text": "Pharmacology of phosphodiesterase-5 inhibitors.. The clinical properties (efficacy and safety profile) of a medicine are related not only to its mode of action, but also to its selectivity for its target (usually a receptor or enzyme) and are also...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5159607529640198,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10730545",
          "text": "Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here?. Research conducted over the last 20 years has established that inflammation of the airways is central to the airway dysfunction that charac...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5107214450836182,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12688198",
          "text": "[PDE-5 inhibitor with improved pharmacokinetics. Far-reaching return to normality].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 83,
          "rerank_score": 0.507214367389679,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17305582",
          "text": "Design of second generation phosphodiesterase 5 inhibitors.. The clinical significance of phosphodiesterase 5 (PDE5) inhibition is increasingly understood following the pioneering work with sildenafil, and the continuing development programmes for...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.49869176745414734,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16526979",
          "text": "PDE5 inhibitors: are there differences?. The introduction of oral agents for the treatment of erectile dysfunction (ED) has revolutionized the treatment of men with erection problems of all severities and etiologies. Sildenafil, available on the w...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4866560399532318,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15095746",
          "text": "Carrying short-acting nitrates is not a contra-indication to the use of PDE5 inhibitors.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 88,
          "rerank_score": 0.4864400625228882,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30385603",
          "text": "An inhaled \"bifunctional\" dual PDE3/4 inhibitor provides additional short-term improvements in lung function compared to existing classes of bronchodilator: implications for future treatment of COPD.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 199,
          "rerank_score": 0.4794835150241852,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18673225",
          "text": "Structure -activity relationships of PDE5 inhibitors.. cGMP has a short-term effect on smooth muscle tone and a longer-term effect on responses to chronic drug treatment or proliferative signals. cGMP-Phosphodiesterase type 5 (PDE5) hydrolizes cGM...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4770560562610626,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16042713",
          "text": "Phosphodiesterase type 5 inhibitors for erectile dysfunction.. The cyclic nucleotide signalling pathway mediates the smooth-muscle relaxing effects of nitric oxide necessary for normal erectile function. Down-regulation of this pathway is central ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4669035077095032,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18998474",
          "text": "[Tadalafil for erectile dysfunction: outstanding efficacy for 36 hours].. Phosphodiesterase type 5 (PDE5) inhibitors are first-line oral medication for erectile dysfunction (ED). Compared with the other two PDE inhibitors (sildenafil and vardenafi...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.46327561140060425,
          "rerank_position": 10
        }
      ],
      "id": "67cc973e81b1027333000011",
      "type": "list",
      "body": "Please list the short half life Phosphodiesterase 5 inhibitors."
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23066308",
        "http://www.ncbi.nlm.nih.gov/pubmed/15335408",
        "http://www.ncbi.nlm.nih.gov/pubmed/26167065",
        "http://www.ncbi.nlm.nih.gov/pubmed/23047498",
        "http://www.ncbi.nlm.nih.gov/pubmed/20465787",
        "http://www.ncbi.nlm.nih.gov/pubmed/24627583",
        "http://www.ncbi.nlm.nih.gov/pubmed/19300123",
        "http://www.ncbi.nlm.nih.gov/pubmed/27995391",
        "http://www.ncbi.nlm.nih.gov/pubmed/12184133",
        "http://www.ncbi.nlm.nih.gov/pubmed/16498275"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23066308",
          "text": "Irritable bowel syndrome: diagnosis and pathogenesis.. Irritable bowel syndrome (IBS) is a common gastrointestinal (GI) disorder that considerably reduces the quality of life. It further represents an economic burden on society due to the high con...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.9189028739929199,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15335408",
          "text": "New pathophysiological mechanisms in irritable bowel syndrome.. Irritable bowel syndrome (IBS) is a functional, multifactorial disease characterized by abdominal pain and erratic bowel habit. Changes in gastrointestinal motor function, enhanced pe...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.9125819206237793,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26167065",
          "text": "Recent developments in the pathophysiology of irritable bowel syndrome.. Irritable bowel syndrome (IBS) is a common gastrointestinal disorder, the pathophysiology of which is not completely known, although it has been shown that genetic/social lea...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.90434730052948,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23047498",
          "text": "Focus on irritable bowel syndrome.. The Irritable bowel syndrome (IBS) is a clinical syndrome characterized by chronic abdominal dis-comfort associated with changes in bowel habits and these symptoms can't be explained by any biochemical or organi...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.9020018577575684,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20465787",
          "text": "Current insights in to the pathophysiology of Irritable Bowel Syndrome.. Irritable Bowel Syndrome (IBS) represents a functional disorder of gastrointestinal tract without the presence of an anatomic defect, in which abdominal pain is relieved with...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.9014290571212769,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24627583",
          "text": "Irritable bowel syndrome: emerging paradigm in pathophysiology.. Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders, characterized by abdominal pain, bloating, and changes in bowel habits. These symptoms cannot be ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8973580598831177,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19300123",
          "text": "Evolving concepts of the pathogenesis of irritable bowel syndrome: to treat the brain or the gut?. Recent in-depth studies of irritable bowel syndrome (IBS) that assessed multiple physiological endpoints in large patient cohorts confirm evidence o...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.892543613910675,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27995391",
          "text": "Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches.. Irritable bowel syndrome (IBS) is a prevalent condition affecting 10-20% of adults in most countries; IBS results in significant morbidity and health care costs. IBS is...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8867543935775757,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12184133",
          "text": "Neuropathophysiology of irritable bowel syndrome.. Widespread symptoms associated with the irritable bowel syndrome (IBS) are abnormal defecation and abdominal pain, both of which can be exacerbated by psychogenic stress. Disordered defecation may...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8826127052307129,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16498275",
          "text": "[The pathophysiology of irritable bowel syndrome: inflammation and motor disorder].. Irritable bowel syndrome (IBS) is one of the most common disorders and a heterogeneous condition in view of symptoms and underlying mechanisms. Though underlying ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8787764310836792,
          "rerank_position": 10
        }
      ],
      "id": "67d722e818b1e36f2e000036",
      "type": "summary",
      "body": "Pathophysiology of irritable bowel syndrome (IBS)."
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23649974",
        "http://www.ncbi.nlm.nih.gov/pubmed/25344858",
        "http://www.ncbi.nlm.nih.gov/pubmed/21933973",
        "http://www.ncbi.nlm.nih.gov/pubmed/27048336",
        "http://www.ncbi.nlm.nih.gov/pubmed/20809868",
        "http://www.ncbi.nlm.nih.gov/pubmed/28072762",
        "http://www.ncbi.nlm.nih.gov/pubmed/22187964",
        "http://www.ncbi.nlm.nih.gov/pubmed/26951083",
        "http://www.ncbi.nlm.nih.gov/pubmed/25139999",
        "http://www.ncbi.nlm.nih.gov/pubmed/39924521"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23649974",
          "text": "The receptor tyrosine kinase Axl in cancer: biological functions and therapeutic implications.. The receptor tyrosine kinase Axl has been implicated in the malignancy of different types of cancer. Emerging evidence of Axl upregulation in numerous ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7901603579521179,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25344858",
          "text": "Axl as a mediator of cellular growth and survival.. The control of cellular growth and proliferation is key to the maintenance of homeostasis. Survival, proliferation, and arrest are regulated, in part, by Growth Arrest Specific 6 (Gas6) through b...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7750683426856995,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21933973",
          "text": "Targeting Axl and Mer kinases in cancer.. Receptor tyrosine kinases (RTK) are cell-surface transmembrane receptors that contain regulated kinase activity within their cytoplasmic domain and play an important role in signal transduction in both nor...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7730034589767456,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27048336",
          "text": "Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells.. Aberrant expression and activation of receptor tyrosine kinases (RTK) is a frequent feature of tumor cells that may underlie tumor aggressiveness. Among RTK, Axl, a membe...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7715857028961182,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20809868",
          "text": "Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors.. IMPORTANCE OF THE FIELD: Axl and/or Mer expression correlates with poor prognosis in several cancers. Until recently, the role of these receptor tyr...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7553103566169739,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28072762",
          "text": "Giving AXL the axe: targeting AXL in human malignancy.. The receptor tyrosine kinase AXL, activated by a complex interaction between its ligand growth arrest-specific protein 6 and phosphatidylserine, regulates various vital cellular processes, in...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7513217926025391,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22187964",
          "text": "Axl-dependent signalling: a clinical update.. Axl is a receptor tyrosine kinase that was originally cloned from cancer cells. Axl belongs to the TAM (Tyro3, Axl and Mertk) family of receptor tyrosine kinases. Gas6 (growth-arrest-specific protein 6...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7464035153388977,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951083",
          "text": "Gene of the month: Axl.. The interaction between Axl receptor tyrosine kinase and its main ligand Gas6 has been implicated in the progression of a wide number of malignancies. More recently, overexpression of Axl has emerged as a key molecular det...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7409855127334595,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25139999",
          "text": "Axl kinase as a key target for oncology: focus on small molecule inhibitors.. Receptor tyrosine kinases (RTK) are transmembrane receptors that regulate signal transduction in cells. As a member of the TAM (Tyro-3, Axl, Mer) RTK subfamily, Axl regu...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7264126539230347,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39924521",
          "text": "AXL signaling in cancer: from molecular insights to targeted therapies.. AXL, a member of the TAM receptor family, has emerged as a potential target for advanced-stage human malignancies. It is frequently overexpressed in different cancers and pla...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7240315079689026,
          "rerank_position": 10
        }
      ],
      "id": "67da17c918b1e36f2e000055",
      "type": "summary",
      "body": "What is the role of the receptor tyrosine kinase AXL in malignancy?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/36596294",
        "http://www.ncbi.nlm.nih.gov/pubmed/3628047",
        "http://www.ncbi.nlm.nih.gov/pubmed/7247762",
        "http://www.ncbi.nlm.nih.gov/pubmed/3832354",
        "http://www.ncbi.nlm.nih.gov/pubmed/3614146",
        "http://www.ncbi.nlm.nih.gov/pubmed/4176628",
        "http://www.ncbi.nlm.nih.gov/pubmed/6880885",
        "http://www.ncbi.nlm.nih.gov/pubmed/27487372",
        "http://www.ncbi.nlm.nih.gov/pubmed/7313431",
        "http://www.ncbi.nlm.nih.gov/pubmed/10382908"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36596294",
          "text": "Pulmonary function tests for evaluating the severity of Duchenne muscular dystrophy disease.. AIM: In Duchenne muscular dystrophy (DMD), lung disease contributes significantly to morbidity and mortality. This study aimed to assess the usefulness o...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6859812140464783,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3628047",
          "text": "[Evaluation of the respiratory function in patients with Duchenne's muscular dystrophy].. The purpose of this investigation was to compare the respiratory function of patients with different clinical stages of Duchenne muscular dystrophy (DMD). Tw...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6813853979110718,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7247762",
          "text": "Loss of strength and functional decline in Duchenne's dystrophy.. Clinical tests of strength and function were performed on 27 ambulatory patients with Duchenne's dystrophy every three months for 2 1/2 years. Linear decline of strength remains a f...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6639292240142822,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3832354",
          "text": "[Prognostic evaluation of the cardiopathy in Duchenne's muscular dystrophy].. As it has now been ascertained that there is cardiac damage during the course of Duchenne muscular dystrophy (DMD), the authors have aimed at evaluating the relationship...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.652432382106781,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3614146",
          "text": "[Vital capacity as a prognostic index in Duchenne's muscular dystrophy].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 72,
          "rerank_score": 0.6496880054473877,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/4176628",
          "text": "Correlations between aldolasaemia and motor unit territory in the evaluation of Duchenne's progressive muscular dystrophy.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 122,
          "rerank_score": 0.6462032198905945,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/6880885",
          "text": "Alterations of the respiratory function in Duchenne's muscular dystrophy. Observations on 14 cases.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 99,
          "rerank_score": 0.6459147930145264,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27487372",
          "text": "Relationship between muscle strength and motor function in Duchenne muscular dystrophy.. OBJECTIVE: To investigate the relationship between muscle strength and motor function and between these variables and age. METHOD: Muscle strength was measure...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6423788070678711,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7313431",
          "text": "[The pattern of myopathic involvement in Duchenne's muscular dystrophy].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 72,
          "rerank_score": 0.6346482038497925,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10382908",
          "text": "Correlation of muscle fiber type measurements with clinical and molecular genetic data in Duchenne muscular dystrophy.. Clinical improvement following surgery in patients with Duchenne muscular dystrophy (DMD) may be influenced by the severity of ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6335299015045166,
          "rerank_position": 10
        }
      ],
      "id": "66301d1d187cba990d000026",
      "type": "yesno",
      "body": "Are respiratory measurements correlated with disease severity in Duchenne Muscular Dystrophy?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28007905",
        "http://www.ncbi.nlm.nih.gov/pubmed/23359680",
        "http://www.ncbi.nlm.nih.gov/pubmed/39030458",
        "http://www.ncbi.nlm.nih.gov/pubmed/38131667",
        "http://www.ncbi.nlm.nih.gov/pubmed/35986737",
        "http://www.ncbi.nlm.nih.gov/pubmed/16369839",
        "http://www.ncbi.nlm.nih.gov/pubmed/16450370",
        "http://www.ncbi.nlm.nih.gov/pubmed/20574456",
        "http://www.ncbi.nlm.nih.gov/pubmed/15882803",
        "http://www.ncbi.nlm.nih.gov/pubmed/32207552"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28007905",
          "text": "Novel UCHL1 mutations reveal new insights into ubiquitin processing.. Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 has been implicated in early-onset progressive neurodegeneration (MIM no. 615491), so far only in one family...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5062264800071716,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23359680",
          "text": "Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration.. Ubiquitin C-terminal hydrolase-L1 (UCHL1), a neuron-specific de-ubiquitinating enzyme, is one of the most abundant proteins i...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4980633854866028,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39030458",
          "text": "Phenotypic variability related to dominant UCHL1 mutations: about three families with optic atrophy and ataxia.. INTRODUCTION: Ubiquitin C-terminal hydrolase L1 (UCHL1) has been associated with a severe, complex autosomal recessive spastic paraple...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.49041807651519775,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38131667",
          "text": "Digenic FLNA and UCHL1 variants resulting in a complex phenotype.. AIM: X-linked variants in Filamin A (FLNA) are associated with the Ehlers-Danlos-syndrome-variant form of periventricular heterotopia, and autosomal dominant variants in ubiquitin ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.468730628490448,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35986737",
          "text": "Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy.. PURPOSE: Biallelic variants in UCHL1 have been associated with a progressive early-onset neurodegenerative dis...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4362603724002838,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16369839",
          "text": "The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease.. An expanded polyglutamine stretch in the huntingtin protein has been identified as the pathogenetic cause of Huntington's disease (HD). Although the length of ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4359121322631836,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16450370",
          "text": "UCHL-1 is not a Parkinson's disease susceptibility gene.. OBJECTIVE: The UCHL-1 gene is widely cited as a susceptibility factor for sporadic Parkinson's disease (PD). The strongest evidence comes from a meta-analysis of small studies that reported...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.42478954792022705,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20574456",
          "text": "The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling.. De-ubiquitinating enzymes (DUBs) can reverse the modifications catalyzed by ubiquitin ligases and as such are beli...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.40442734956741333,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15882803",
          "text": "UCHL1 is associated with Parkinson's disease: a case-unaffected sibling and case-unrelated control study.. To avoid the possible confounding effect of population stratification, we employed a discordant sibling study design and a liberalization of...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4008990526199341,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32207552",
          "text": "Ubiquitin carboxy-terminal hydrolase L1 - physiology and pathology.. Ubiquitin C-terminal hydrolase 1 (UCHL1) is an enzyme unique for its multiple activity - both ligase and hydrolase. UCHL1 was first identified as an abundant protein found in the...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.39902666211128235,
          "rerank_position": 10
        }
      ],
      "id": "67d3518718b1e36f2e000008",
      "type": "factoid",
      "body": "Which disease is caused by heterozygous UCHL1 loss-of-function variants?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26791841",
        "http://www.ncbi.nlm.nih.gov/pubmed/24985058",
        "http://www.ncbi.nlm.nih.gov/pubmed/23297721",
        "http://www.ncbi.nlm.nih.gov/pubmed/24051581",
        "http://www.ncbi.nlm.nih.gov/pubmed/25475573",
        "http://www.ncbi.nlm.nih.gov/pubmed/15918011",
        "http://www.ncbi.nlm.nih.gov/pubmed/24876733",
        "http://www.ncbi.nlm.nih.gov/pubmed/18081659",
        "http://www.ncbi.nlm.nih.gov/pubmed/23559319",
        "http://www.ncbi.nlm.nih.gov/pubmed/22242554"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26791841",
          "text": "Neoadjuvant Treatment for Surgically Resectable Metastatic Colorectal Cancer: Is There an Optimal Succession?",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 109,
          "rerank_score": 0.7274329662322998,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24985058",
          "text": "Potentially resectable metastatic colorectal cancer: an individualized approach to conversion therapy.. Colorectal cancer is one of the most common cancers worldwide. In recent years, the survival of patients with metastatic disease has improved d...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7134334444999695,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23297721",
          "text": "Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement.. Systemic therapy for colorectal cancer liver metastases (CRLM) has undergone significant development in the past 15â€‰years. Therapy regimens co...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7019253373146057,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24051581",
          "text": "Surgery for colorectal liver metastases.. Half of all patients with colorectal cancer develop metastatic disease. The liver is the principal site for metastases, and surgical resection is the only modality that offers the potential for long-term c...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6692025065422058,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25475573",
          "text": "Surgical management of hepatic metastases of colorectal cancer.. For the 20% of patients with resectable colorectal liver metastases (CRLM), hepatic resection is safe, effective and potentially curative. Factors related to the primary and metastat...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6652311682701111,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15918011",
          "text": "[Standard surgical resection of colorectal liver metastases].. Liver resection for colorectal metastases can be performed with curative intent in about 15-20% of patients. From a surgical point of view, achieving a radical (R0) resection is of par...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6642643213272095,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24876733",
          "text": "Role of surgery in colorectal cancer liver metastases.. Colorectal carcinoma (CRC) is the third most common cancer, and approximately 35%-55% of patients with CRC will develop hepatic metastases during the course of their disease. Surgical resecti...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6548393964767456,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18081659",
          "text": "Review article: Multimodality treatment of liver metastases increases suitability for surgical treatment.. BACKGROUND: Liver metastases of colorectal cancer occur frequently, but only 10-20% are eligible for liver surgery. Recent new developments ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6547845602035522,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23559319",
          "text": "[Management of synchronous colorectal liver metastases].. At time of diagnosis, 10 to 25% of patients with colorectal cancer present synchronous liver metastases. The treatment of such patients remains controversial without any evidence based orga...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6500743627548218,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22242554",
          "text": "Simultaneous surgery for primary colorectal cancer and metastatic lesions?. Approximately 20-25% of patients with colorectal cancer present with liver metastases at the time of diagnosis. Traditionally, resection of the primary tumor has been advo...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6486127972602844,
          "rerank_position": 10
        }
      ],
      "id": "662154f0b9f8b89d7e000009",
      "type": "factoid",
      "body": "What is the most appropriate systemic treatment for conversion therapy in colorectal cancer with potentially resectable liver metastasis?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/36113764",
        "http://www.ncbi.nlm.nih.gov/pubmed/16643767",
        "http://www.ncbi.nlm.nih.gov/pubmed/9097734",
        "http://www.ncbi.nlm.nih.gov/pubmed/38977082",
        "http://www.ncbi.nlm.nih.gov/pubmed/9891890",
        "http://www.ncbi.nlm.nih.gov/pubmed/34509436",
        "http://www.ncbi.nlm.nih.gov/pubmed/24105633",
        "http://www.ncbi.nlm.nih.gov/pubmed/15804763",
        "http://www.ncbi.nlm.nih.gov/pubmed/32950958",
        "http://www.ncbi.nlm.nih.gov/pubmed/11284745"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36113764",
          "text": "Interplay between aging and other factors of the pathogenesis of age-related macular degeneration.. Age-related macular degeneration (AMD) is a complex eye disease with the retina as the target tissue and aging as per definition the most serious r...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6244451403617859,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16643767",
          "text": "[Aging and age-related macular degeneration].. Aging is a common feature of biological changes in the eye, especially in the retina. It is recognized that the pathogenesis of age-related macular degeneration (AMD) involves changes of RPE-Bruch mem...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6162396669387817,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9097734",
          "text": "Pathogenesis of AMD.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 20,
          "rerank_score": 0.6149964332580566,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38977082",
          "text": "Aging of the eye: Lessons from cataracts and age-related macular degeneration.. Aging is the greatest risk factor for chronic human diseases, including many eye diseases. Geroscience aims to understand the effects of the aging process on these dis...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6119077205657959,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9891890",
          "text": "Age-related macular degeneration: review of pathogenesis.. Age-related macular degeneration is a condition (a) characterized by accumulation of membranous debris on both sides of the retinal pigment epithelium (RPE) basement membrane. Clinical man...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5937421321868896,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34509436",
          "text": "An Update on the Hemodynamic Model of Age-Related Macular Degeneration.. PURPOSE: To provide an update on the hemodynamic model of age-related macular degeneration (AMD). DESIGN: Evidence-based perspective. METHODS: Review of the literature and ex...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5756710171699524,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24105633",
          "text": "Mechanisms of age-related macular degeneration and therapeutic opportunities.. As the age of the population increases in many nations, age-related degenerative diseases pose significant socioeconomic challenges. One of the key degenerative disease...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5721519589424133,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15804763",
          "text": "Immunological factors in the pathogenesis and treatment of age-related macular degeneration.. Recent findings indicate that immunological factors are involved not only in the pathogenesis of age-related macular degeneration (AMD), but also in its ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5578901767730713,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32950958",
          "text": "Role of retinal pigment epithelium in age-related macular disease: a systematic review.. Age-related macular disease (AMD) is a major cause of blindness and there is little treatment currently available by which the progress of the basic disorder ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.553885817527771,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11284745",
          "text": "Ocular perfusion and age-related macular degeneration.. PURPOSE: To review the role of ocular perfusion in the pathophysiology of age-related macular degeneration (AMD), the leading cause of irreversible blindness in the industrialized world. METH...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5538531541824341,
          "rerank_position": 10
        }
      ],
      "id": "67c847f581b1027333000003",
      "type": "yesno",
      "body": "Is age an underlying factor in the eye disease AMD?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/24983096",
        "http://www.ncbi.nlm.nih.gov/pubmed/27028561",
        "http://www.ncbi.nlm.nih.gov/pubmed/27290831",
        "http://www.ncbi.nlm.nih.gov/pubmed/28429288",
        "http://www.ncbi.nlm.nih.gov/pubmed/30875715",
        "http://www.ncbi.nlm.nih.gov/pubmed/30311585",
        "http://www.ncbi.nlm.nih.gov/pubmed/29267910",
        "http://www.ncbi.nlm.nih.gov/pubmed/26925496",
        "http://www.ncbi.nlm.nih.gov/pubmed/27509655",
        "http://www.ncbi.nlm.nih.gov/pubmed/26996139"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24983096",
          "text": "Zika virus.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 11,
          "rerank_score": 0.8752036094665527,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27028561",
          "text": "Zika Virus.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 11,
          "rerank_score": 0.8752036094665527,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27290831",
          "text": "[Zika virus].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 13,
          "rerank_score": 0.8593326807022095,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28429288",
          "text": "Zika virus, a novel mosquito-borne congenital virus infection.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 62,
          "rerank_score": 0.8049919009208679,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30875715",
          "text": "New Advances on Zika Virus Research.. Zika virus (ZIKV) is an emerging mosquito-borne member of the Flaviviridae family that has historically been known to cause sporadic outbreaks, associated with a mild febrile illness, in Africa and Southeast A...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7579647302627563,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30311585",
          "text": "Zika Virus: A Critical Analysis and Pharmaceutical Perspectives.. Zika virusÂ belongs to family of virusesÂ 'Flaviviridae' and spreads mostlyÂ by daytime-activeÂ AedesÂ mosquitoes. The resulting infection is known asÂ Zika fever. It is usually asymptoma...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7415016889572144,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29267910",
          "text": "Zika Virus Mosquito Vectors: Competence, Biology, and Vector Control.. Zika virus (ZIKV) (Flaviviridae, Flavivirus) has become one of the most medically important mosquito-borne viruses because of its ability to cause microcephaly in utero and Gui...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7409050464630127,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26925496",
          "text": "The Zika outbreak of the 21st century.. The Zika virus outbreak has captivated the attention of the global audience and information has spread rapidly and wildly through the internet and other media channels. This virus was first identified in 194...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7354499697685242,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27509655",
          "text": "[ZIKA--VIRUS INFECTION].. This review summarizes the knowledge of the scientific community for Zika-virus infection. It became popular because of severe congenital damage causes of CNS in newborns whose mothers are infected during pregnancy, as we...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7298092246055603,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26996139",
          "text": "Zika virus: History, emergence, biology, and prospects for control.. Zika virus (ZIKV), a previously obscure flavivirus closely related to dengue, West Nile, Japanese encephalitis and yellow fever viruses, has emerged explosively since 2007 to cau...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7234708666801453,
          "rerank_position": 10
        }
      ],
      "id": "67d7fe2618b1e36f2e000044",
      "type": "factoid",
      "body": "Vector of zika virus."
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/30946477",
        "http://www.ncbi.nlm.nih.gov/pubmed/29383547",
        "http://www.ncbi.nlm.nih.gov/pubmed/18497759",
        "http://www.ncbi.nlm.nih.gov/pubmed/20145155",
        "http://www.ncbi.nlm.nih.gov/pubmed/29387965",
        "http://www.ncbi.nlm.nih.gov/pubmed/34894431",
        "http://www.ncbi.nlm.nih.gov/pubmed/39893170",
        "http://www.ncbi.nlm.nih.gov/pubmed/27617697",
        "http://www.ncbi.nlm.nih.gov/pubmed/29849920",
        "http://www.ncbi.nlm.nih.gov/pubmed/20941832"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30946477",
          "text": "The landscape of the mesenchymal signature in brain tumours.. The complexity of glioblastoma multiforme, the most common and lethal variant of gliomas, is reflected by cellular and molecular heterogeneity at both the inter- and intra-tumoural leve...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7141351699829102,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29383547",
          "text": "New aspects of glioblastoma multiforme revealed by similarities between neural and glioblastoma stem cells.. Neural stem cells (NSCs) undergo self-renewal and generate neurons and glial cells under the influence of specific signals from surroundin...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6741672158241272,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18497759",
          "text": "Mesenchymal differentiation of glioblastoma stem cells.. Glioblastoma multiforme is a severe form of cancer most likely arising from the transformation of stem or progenitor cells resident in the brain. Although the tumorigenic population in gliob...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6432064771652222,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20145155",
          "text": "Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin.. Glioblastoma multiforme (GBM) is paradigmatic for the investigation of cancer stem cells (CSC) in solid tumors. Growing e...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.638648509979248,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29387965",
          "text": "Cell biology of glioblastoma multiforme: from basic science to diagnosis and treatment.. First described in the 1800s, glioblastoma multiforme (GBM), a class IV neoplasm with astrocytic differentiation, as per the revised 2016 World Health Organiz...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6335469484329224,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34894431",
          "text": "Transcription factors in glioblastoma - Molecular pathogenesis and clinical implications.. Glioblastoma, also known as glioblastoma multiforme (GBM), is one of the most lethal human cancers, however, the molecular mechanisms driving GBM remain lar...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6290134191513062,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39893170",
          "text": "Network analyses of brain tumor multiomic data reveal pharmacological opportunities to alter cell state transitions.. Glioblastoma Multiforme (GBM) remains a particularly difficult cancer to treat, and survival outcomes remain poor. In addition to...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6161242723464966,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27617697",
          "text": "The Epithelial-to-Mesenchymal Transition-Like Process in Glioblastoma: An Updated Systematic Review and In Silico Investigation.. Glioblastoma multiforme (GBM) is the most aggressive form of brain cancer due to its highly invasive nature that impe...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.612671971321106,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29849920",
          "text": "Longevity-Related Gene Transcriptomic Signature in Glioblastoma Multiforme.. Glioblastoma multiforme (GBM) (grade IV astrocytoma) has been assumed to be the most fatal type of glioma with low survival and high recurrence rates, even after prompt s...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6060998439788818,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20941832",
          "text": "Functional and molecular characterization of glioblastoma multiforme-derived cancer stem cells.. PURPOSE: Brain tumors are the leading cause of cancer mortality in children and remain incurable despite advances in surgery and adjuvant therapies. T...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6055530309677124,
          "rerank_position": 10
        }
      ],
      "id": "67d7503018b1e36f2e00003e",
      "type": "list",
      "body": "What are the main transcription factors driving the mesenchymal-like (MES-like) state of glioblastoma multiforme?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/34537679",
        "http://www.ncbi.nlm.nih.gov/pubmed/37565404",
        "http://www.ncbi.nlm.nih.gov/pubmed/31824583",
        "http://www.ncbi.nlm.nih.gov/pubmed/38978724",
        "http://www.ncbi.nlm.nih.gov/pubmed/38193360",
        "http://www.ncbi.nlm.nih.gov/pubmed/32151945",
        "http://www.ncbi.nlm.nih.gov/pubmed/38266156",
        "http://www.ncbi.nlm.nih.gov/pubmed/37165958",
        "http://www.ncbi.nlm.nih.gov/pubmed/38916676",
        "http://www.ncbi.nlm.nih.gov/pubmed/32548277"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34537679",
          "text": "Investigating RFC1 expansions in sporadic amyotrophic lateral sclerosis.. A homozygous AAGGG repeat expansion within the RFC1 gene was recently described as a common cause of CANVAS syndrome. We examined 1069 sporadic ALS patients for the presence...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6204236149787903,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37565404",
          "text": "Non-GAA Repeat Expansions in FGF14 Are Likely Not Pathogenic-Reply to: \"Shaking Up Ataxia: FGF14 and RFC1 Repeat Expansions in Affected and Unaffected Members of a Chilean Family\".",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 180,
          "rerank_score": 0.574858546257019,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31824583",
          "text": "Investigation of the RFC1 Repeat Expansion in a Canadian and a Brazilian Ataxia Cohort: Identification of Novel Conformations.. A biallelic pentanucleotide expansion in the RFC1 gene has been reported to be a common cause of late-onset ataxia. In ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5679152011871338,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38978724",
          "text": "Pathologic RFC1 repeat expansions do not contribute to the development of inflammatory neuropathies.. Biallelic expansions of the AAGGG repeat in the replication factor C subunit 1 (RFC1) have recently been described to be responsible for cerebell...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5640356540679932,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38193360",
          "text": "Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease.. RFC1 disease, caused by biallelic repeat expansion in RFC1, is clinically heterogeneous in terms of age of onset, disease progression and phenotype. We inv...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5570946931838989,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32151945",
          "text": "No biallelic intronic AAGGG repeat expansion in RFC1 was found in patients with late-onset ataxia and MSA.. We screened the RFC1 intronic AAGGG repeat expansions in late-onset ataxia cases, MSA patients and controls. The data suggested that no bia...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5524989366531372,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38266156",
          "text": "Structural investigation of pathogenic RFC1 AAGGG pentanucleotide repeats reveals a role of G-quadruplex in dysregulated gene expression in CANVAS.. An expansion of AAGGG pentanucleotide repeats in the replication factor C subunit 1 (RFC1) gene is...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5488375425338745,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37165958",
          "text": "Detection of the ACAGG Repeat Motif in RFC1 in Two Dutch Ataxia Families.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 73,
          "rerank_score": 0.54649817943573,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38916676",
          "text": "Analysis and occurrence of biallelic pathogenic repeat expansions in RFC1 in a German cohort of patients with a main clinical phenotype of motor neuron disease.. Biallelic pathogenic repeat expansions in RFC1 were recently identified as molecular ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5416063070297241,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32548277",
          "text": "Intronic pentanucleotide expansion in the replication factor 1 gene (RFC1) is a major cause of adult-onset ataxia.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 114,
          "rerank_score": 0.5354132652282715,
          "rerank_position": 10
        }
      ],
      "id": "67d34fb318b1e36f2e000007",
      "type": "factoid",
      "body": "Which role does AAAGG have in RFC1 repeat expansions?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/34909395",
        "http://www.ncbi.nlm.nih.gov/pubmed/28825047",
        "http://www.ncbi.nlm.nih.gov/pubmed/34077519",
        "http://www.ncbi.nlm.nih.gov/pubmed/33005848",
        "http://www.ncbi.nlm.nih.gov/pubmed/26457759",
        "http://www.ncbi.nlm.nih.gov/pubmed/28741479",
        "http://www.ncbi.nlm.nih.gov/pubmed/37345083",
        "http://www.ncbi.nlm.nih.gov/pubmed/32463385",
        "http://www.ncbi.nlm.nih.gov/pubmed/37970108",
        "http://www.ncbi.nlm.nih.gov/pubmed/30796810"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34909395",
          "text": "Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approach.. The identification of several genetic mutations in colorectal cancer (CRC) has allowed a better comprehension of the prognosis and response to diffe...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7681596279144287,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28825047",
          "text": "Consensus Molecular Subtypes of Colorectal Cancer and their Clinical Implications.. The colorectal cancer (CRC) Subtyping Consortium has unified six independent molecular classification systems, based on gene expression data, into a single consens...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7628443241119385,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34077519",
          "text": "Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis.. BACKGROUND: The consensus molecular subtypes (CMSs) of colorectal cancer (CRC) capture tumor heterogeneity at the gene-expression level. C...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7618085145950317,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33005848",
          "text": "Investigation of colorectal cancer in accordance with consensus molecular subtype classification.. The classification of colorectal cancer (CRC) plays a pivotal role in predicting a patient's prognosis and determining treatment strategies. The con...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7545980215072632,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26457759",
          "text": "The consensus molecular subtypes of colorectal cancer.. Colorectal cancer (CRC) is a frequently lethal disease with heterogeneous outcomes and drug responses. To resolve inconsistencies among the reported gene expression-based CRC classifications ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7278549671173096,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28741479",
          "text": "Colorectal Cancer Subtypes: Developmental Origin and Microenvironmental Regulation.. Cancer is a heterogeneous disease and many cancer types do not represent a single entity, but are composed of biologically and clinically diverse subtypes. The su...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7274397611618042,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37345083",
          "text": "Principles of Molecular Utility for CMS Classification in Colorectal Cancer Management.. Colorectal cancer (CRC) is the second cause of cancer-related deaths in both sexes globally and presents different clinical outcomes that are described by a r...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7267494201660156,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32463385",
          "text": "Consensus molecular subtypes (CMS) in metastatic colorectal cancer - personalized medicine decision.. Background Colorectal cancer (CRC) is one of the most common types of cancer in the world. Metastatic disease is still incurable in most of these...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.72062087059021,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37970108",
          "text": "Classification of patients with metastatic colorectal cancer into consensus molecular subtypes into real-world: A pilot study.. BACKGROUND: Colorectal cancer is a complex disease with high mortality rates. Over time, the treatment of metastatic co...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.719837486743927,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30796810",
          "text": "Context matters-consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials.. The Colorectal Cancer Subtyping Consortium identified four gene expression consensus molecular subtypes, CMS1 (immune), CMS2 (canonical), CMS3 (m...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7167459726333618,
          "rerank_position": 10
        }
      ],
      "id": "662fc277187cba990d000013",
      "type": "yesno",
      "body": "Does the consensus molecular subtype (CMS) classification for colorectal cancer any use in routine clinical practice?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/19736396",
        "http://www.ncbi.nlm.nih.gov/pubmed/27104824",
        "http://www.ncbi.nlm.nih.gov/pubmed/29427800",
        "http://www.ncbi.nlm.nih.gov/pubmed/22591620",
        "http://www.ncbi.nlm.nih.gov/pubmed/19685828",
        "http://www.ncbi.nlm.nih.gov/pubmed/26228363",
        "http://www.ncbi.nlm.nih.gov/pubmed/36870204",
        "http://www.ncbi.nlm.nih.gov/pubmed/30155958",
        "http://www.ncbi.nlm.nih.gov/pubmed/27003987",
        "http://www.ncbi.nlm.nih.gov/pubmed/16701503"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19736396",
          "text": "Established and potential risk factors for Clostridum difficile infection.. Clostridium difficile is the aetiological agent for almost all cases of pseudo membranous colitis and 15-25% of antibiotic associated diarrhoea. In recent years, C. diffic...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6682868003845215,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27104824",
          "text": "Bacterial Intestinal Superinfections in Inflammatory Bowel Diseases Beyond Clostridum difficile.. Besides genetics and environmental factors, intestinal microbiota seem to play a major role in the pathogenesis of inflammatory bowel diseases. For m...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5718560218811035,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29427800",
          "text": "New insights into transmission of Clostridium difficile infection-narrative review.. BACKGROUND: Traditionally, Clostridium difficile has been considered a typical healthcare-associated pathogen-that is, one transmitted within healthcare facilitie...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5492583513259888,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22591620",
          "text": "Statins and Clostridum difficile: a clinically relevant interaction?",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 68,
          "rerank_score": 0.5362603068351746,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19685828",
          "text": "[Clostridum difficile associated disease in Latin America].. Clostridium difficile associated disease (CDAD) has shown a sustained increase worldwide over the last ten years. However, there are few studies on this topic in Latin America. We conduc...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5262737274169922,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26228363",
          "text": "The impact of Clostridum difficile on surgical rate among ulcerative colitis patients: A systemic review and meta-analysis.. There is growing recognition of the impact of Clostridum difficile infection (CDI) on patients with inflammatory bowel dis...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5107980966567993,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36870204",
          "text": "Clostridial diarrheas in piglets: A review.. Clostridium perfringens type C and Clostridioides difficile are the main enteric clostridial pathogens of swine and are both responsible for neonatal diarrhea in this species. The role of Clostridum per...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5089600086212158,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30155958",
          "text": "Cardiac allograft vasculopathy following fecal microbiota transplantation for recurrent C. difficile infection.. We report the case of a 3-year-old male who developed recurrent Clostridium difficile infection after receiving an orthotopic heart tr...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.49767565727233887,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27003987",
          "text": "Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections.. Antibiotic-associated diarrhea (AAD) and Clostridium difficile infections (CDI) have been well studied for adult cases, but not as well in the ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4775744676589966,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16701503",
          "text": "The development of Clostridium difficile genetic systems.. Clostridum difficile is a major cause of healthcare-associated disease in the western world, and is particularly prominent in the elderly. Its incidence is rising concomitant with increasi...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.43393200635910034,
          "rerank_position": 10
        }
      ],
      "id": "67cddce881b102733300001c",
      "type": "list",
      "body": "Please list major complications of Clostridum Difficile infection."
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22375502",
        "http://www.ncbi.nlm.nih.gov/pubmed/16817431",
        "http://www.ncbi.nlm.nih.gov/pubmed/14704263",
        "http://www.ncbi.nlm.nih.gov/pubmed/15693578",
        "http://www.ncbi.nlm.nih.gov/pubmed/17893687",
        "http://www.ncbi.nlm.nih.gov/pubmed/10352925",
        "http://www.ncbi.nlm.nih.gov/pubmed/17454455",
        "http://www.ncbi.nlm.nih.gov/pubmed/26819214",
        "http://www.ncbi.nlm.nih.gov/pubmed/18087838",
        "http://www.ncbi.nlm.nih.gov/pubmed/26137726"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22375502",
          "text": "[Polycystic ovarian syndrome].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 30,
          "rerank_score": 0.9302666187286377,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16817431",
          "text": "[Polycystic ovarian syndrome].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 30,
          "rerank_score": 0.9302666187286377,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14704263",
          "text": "Polycystic ovary syndrome.. Women with polycystic ovarian syndrome have chronic anovulation and androgen excess not attributable to another cause. This condition occurs in approximately 4% of women. The fundamental pathophysiologic defect is unkno...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8867834806442261,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15693578",
          "text": "Diagnosis and treatment of polycystic ovarian syndrome.. Polycystic ovarian syndrome is a hormonal disturbance that results in a collection of symptoms and has wide-ranging health implications. There is evidence that it may run in families, and it...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8842112421989441,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17893687",
          "text": "The reproductive phenotype in polycystic ovary syndrome.. The symptoms of women with polycystic ovary syndrome (PCOS) include hirsutism and irregular menstrual bleeding due to ovarian androgen excess and chronic anovulation. Typically, these featu...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8778786063194275,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10352925",
          "text": "Diagnosis of polycystic ovary syndrome.. The clinical features of polycystic ovary syndrome (PCOS) include hirsutism and irregular menses, which are the results of ovarian hyperandrogenism and chronic, unopposed estrogen secretion. The discovery t...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8490592837333679,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17454455",
          "text": "Therapeutic options in the polycystic ovary syndrome.. The polycystic ovary syndrome is the most common endocrine disorder affecting women. It is a heterogeneous familial condition of uncertain aetiology. The diagnosis is made by the detection of ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8409844636917114,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26819214",
          "text": "[Metabolic and Reproductive Consequences of the Polycystic Ovary Syndrome (PCOS)].. Polycystic ovarian syndrome represents the most common endocrine disease of women of reproductive age. Symptoms include metabolic, gynecologic and cosmetic feature...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.833497166633606,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18087838",
          "text": "[Long-term health consequences of polycystic ovaries syndrome: metabolic, cardiovascular and oncological aspects].. The polycystic ovary syndrome (PCOS), then called the Stein-Leventhal syndrome, was first described in 1935. Originally, diagnosis ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8299174904823303,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26137726",
          "text": "Polycystic Ovarian Syndrome: A Primer.. Polycystic ovary syndrome (PCOS) affects 8-10 percent of reproductive-aged females, making it the most common state of endocrine dysfunction in women. Patients with PCOS are often treated for the signs and s...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8291077613830566,
          "rerank_position": 10
        }
      ],
      "id": "67d43cd218b1e36f2e000011",
      "type": "list",
      "body": "Symptoms of polycystic ovarian syndrome."
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/38052500",
        "http://www.ncbi.nlm.nih.gov/pubmed/34153742",
        "http://www.ncbi.nlm.nih.gov/pubmed/39042298",
        "http://www.ncbi.nlm.nih.gov/pubmed/20142420",
        "http://www.ncbi.nlm.nih.gov/pubmed/27128881",
        "http://www.ncbi.nlm.nih.gov/pubmed/24982138",
        "http://www.ncbi.nlm.nih.gov/pubmed/30347186",
        "http://www.ncbi.nlm.nih.gov/pubmed/30770136",
        "http://www.ncbi.nlm.nih.gov/pubmed/37286422",
        "http://www.ncbi.nlm.nih.gov/pubmed/21372517"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38052500",
          "text": "Features, Fates, and Functions of Oligodendrocyte Precursor Cells.. Oligodendrocyte precursor cells (OPCs) are a central nervous system resident population of glia with a distinct molecular identity and an ever-increasing list of functions. OPCs g...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7497905492782593,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34153742",
          "text": "Oligodendrocyte progenitor cell fate and function in development and disease.. Differentiation of oligodendrocyte progenitor cells (OPCs) into myelination-capable mature oligodendrocytes is essential for proper function of the central nervous syst...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7102332711219788,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39042298",
          "text": "A New Acquaintance of Oligodendrocyte Precursor Cells in the Central Nervous System.. Oligodendrocyte precursor cells (OPCs) are a heterogeneous multipotent population in the central nervous system (CNS) that appear during embryogenesis and persis...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7095581889152527,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20142420",
          "text": "Tapping into the glial reservoir: cells committed to remaining uncommitted.. The development and maturation of the oligodendrocyte requires a series of highly orchestrated events that coordinate the proliferation and differentiation of the oligode...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7010145783424377,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27128881",
          "text": "The environment rules: spatiotemporal regulation of oligodendrocyte differentiation.. During development oligodendrocyte precursor cells (OPCs) rapidly proliferate and migrate throughout the central nervous system. The mobilization of OPCs is foll...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.699015736579895,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24982138",
          "text": "Transcription factor induction of human oligodendrocyte progenitor fate and differentiation.. Human oligodendrocyte progenitor cell (OPC) specification and differentiation occurs slowly and limits the potential for cell-based treatment of demyelin...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6981297731399536,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30347186",
          "text": "Sequential specification of oligodendrocyte lineage cells by distinct levels of Hedgehog and Notch signaling.. During development of the central nervous system oligodendrocyte precursor cells (OPCs) give rise to both myelinating oligodendrocytes a...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6952687501907349,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30770136",
          "text": "Molecular Control of Oligodendrocyte Development.. Myelin is a multilayer lipid membrane structure that wraps and insulates axons, allowing for the efficient propagation of action potentials. During developmental myelination of the central nervous...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.689905047416687,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37286422",
          "text": "Emerging roles of oligodendrocyte precursor cells in neural circuit development and remodeling.. Oligodendrocyte precursor cells (OPCs) are non-neuronal brain cells that give rise to oligodendrocytes, glia that myelinate the axons of neurons in th...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.686684250831604,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21372517",
          "text": "Differential gene expression in oligodendrocyte progenitor cells, oligodendrocytes and type II astrocytes.. Oligodendrocyte precursor cells (OPCs) are bipotential progenitor cells that can differentiate into myelin-forming oligodendrocytes or func...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6836137771606445,
          "rerank_position": 10
        }
      ],
      "id": "67d9f6a418b1e36f2e000051",
      "type": "list",
      "body": "What are the lineage transcription factors of oligodendrocyte progenitor cells (OPCs)?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/39103897",
        "http://www.ncbi.nlm.nih.gov/pubmed/17686445",
        "http://www.ncbi.nlm.nih.gov/pubmed/21376511",
        "http://www.ncbi.nlm.nih.gov/pubmed/20558582",
        "http://www.ncbi.nlm.nih.gov/pubmed/34766461",
        "http://www.ncbi.nlm.nih.gov/pubmed/37428988",
        "http://www.ncbi.nlm.nih.gov/pubmed/24293473",
        "http://www.ncbi.nlm.nih.gov/pubmed/25527907",
        "http://www.ncbi.nlm.nih.gov/pubmed/31539267",
        "http://www.ncbi.nlm.nih.gov/pubmed/28518058"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39103897",
          "text": "Integrating knowledge graphs into machine learning models for survival prediction and biomarker discovery in patients with non-small-cell lung cancer.. Accurate survival prediction for Non-Small Cell Lung Cancer (NSCLC) patients remains a signific...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6227418184280396,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17686445",
          "text": "How could pharmacogenomics help improve patient survival?. Increasing knowledge regarding multiple genetic disturbances found in human lung cancers, particularly non-small cell lung cancer (NSCLC), have enabled predictive markers to be used in spe...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5060673952102661,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21376511",
          "text": "[Prognostic and predictive biomarkers in non-small cell lung cancers. From conditioned registrations to routine molecular mapping of lung cancers: Methodological issues].. Targeted therapies booming and new efficacious cytotoxics emergence in non-...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5033731460571289,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20558582",
          "text": "How accurate are physicians in the prediction of patient survival in advanced lung cancer?. BACKGROUND: Because most cases of non-small cell lung cancer (NSCLC) are diagnosed at an advanced stage with a poor prognosis, patient inclusion in clinica...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.497694194316864,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34766461",
          "text": "The need for speed in advanced non-small cell lung cancer: A population kinetics assessment.. BACKGROUND: Systemic therapy prolongs overall survival (OS) in advanced non-small cell lung cancer (NSCLC), but diagnostic tests, staging and molecular p...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4813147187232971,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37428988",
          "text": "Machine Learning-Assisted Recurrence Prediction for Patients With Early-Stage Non-Small-Cell Lung Cancer.. PURPOSE: Stratifying patients with cancer according to risk of relapse can personalize their care. In this work, we provide an answer to the...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4700683355331421,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24293473",
          "text": "Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy.. The aim of this article is to summarise the published data on prognostic and predictive biomarkers for early-stage non-small cell ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.463776171207428,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25527907",
          "text": "Evaluation of RECIST in chemotherapy-treated lung cancer: the Pharmacogenoscan Study.. BACKGROUND: Response Evaluation Criteria in Solid Tumors (RECIST) are widely used to assess the effect of chemotherapy in patients with cancer. We hypothesised ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.450011283159256,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31539267",
          "text": "Machine-Learning and Stochastic Tumor Growth Models for Predicting Outcomes in Patients With Advanced Non-Small-Cell Lung Cancer.. PURPOSE: The prediction of clinical outcomes for patients with cancer is central to precision medicine and the desig...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4446916878223419,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28518058",
          "text": "Prediction of NSCLC recurrence from microarray data with GEP.. Lung cancer is one of the deadliest diseases in the world. Non-small cell lung cancer (NSCLC) is the most common and dangerous type of lung cancer. Despite the fact that NSCLC is preve...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4375729262828827,
          "rerank_position": 10
        }
      ],
      "id": "67d7531018b1e36f2e000041",
      "type": "list",
      "body": "Data from which clinical trials have been used to demonstrate use of knowledge graphs for NSCLC survival prediction?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/20233459",
        "http://www.ncbi.nlm.nih.gov/pubmed/24667094",
        "http://www.ncbi.nlm.nih.gov/pubmed/8607012",
        "http://www.ncbi.nlm.nih.gov/pubmed/31777463",
        "http://www.ncbi.nlm.nih.gov/pubmed/3035696",
        "http://www.ncbi.nlm.nih.gov/pubmed/27339646",
        "http://www.ncbi.nlm.nih.gov/pubmed/8829326",
        "http://www.ncbi.nlm.nih.gov/pubmed/25469031",
        "http://www.ncbi.nlm.nih.gov/pubmed/1847273",
        "http://www.ncbi.nlm.nih.gov/pubmed/8813770"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20233459",
          "text": "In the beginning there was colectomy: current surgical options in familial adenomatous polyposis.. Multiple colonic polyps, almost guaranteed colorectal cancer by the age of forty-five and an increased risk of non-colonic cancers characterise the ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7543259859085083,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24667094",
          "text": "[Surgical options for familial adenomatous polyposis depending on genetic factors].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 83,
          "rerank_score": 0.7514613270759583,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8607012",
          "text": "Surgical options for familial adenomatous polyposis.. Familial adenomatous polyposis (FAP) is a genetic disorder transmitted in an autosomal dominant pattern. One-half of members of an affected family will carry the gene, and all carriers will suc...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7481940984725952,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31777463",
          "text": "Adenomatous Polyposis Syndromes: Diagnosis and Management.. Familial adenomatous polyposis (FAP) syndromes make up fewer than 1% of patients diagnosed with colorectal cancer each year. Patients with familial polyposis syndromes including FAP, atte...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7481843829154968,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3035696",
          "text": "Surgical alternatives in the treatment of polyposis coli.. The history of familial polyposis coli and its various surgical treatment alternatives are presented. Each form of treatment has advantages and disadvantages. The menu of alternatives allo...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7408339977264404,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27339646",
          "text": "[Surgical aspects of indications and techniques for adenomatous polyposis variants].. Due to the advances in molecular genetic diagnostics of adenomatous polyposis variants, identification of patients with a genetic predisposition and their at ris...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7270376086235046,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8829326",
          "text": "Operations for familial adenomatous polyposis.. The purpose of this article is to discuss the advantages and disadvantages of surgical procedures designed to eliminate the risk of colorectal cancer, the surgical treatment of extracolonic polyps, a...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7221981287002563,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25469031",
          "text": "Surgical treatment of familial adenomatous polyposis: dilemmas and current recommendations.. Familial adenomatous polyposis (FAP) is an autosomal dominant inherited syndrome characterized by multiple adenomatous polyps (predisposing to colorectal ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7214018702507019,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1847273",
          "text": "Choice of operation in familial adenomatous polyposis.. There are 3 surgical options for patients who have familial adenomatous polyposis. None of them guarantees a 100% cure of the disease, although they all minimize or eliminate the risk of colo...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7191839218139648,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8813770",
          "text": "Choice of prophylactic surgery for the large bowel component of familial adenomatous polyposis.. The surgical options for treating the large bowel component of familial adenomatous polyposis are total proctocolectomy, colectomy with ileorectal ana...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.710936963558197,
          "rerank_position": 10
        }
      ],
      "id": "660999a0fdcbea915f00001a",
      "type": "list",
      "body": "What are the colorectal surgical options for patients with Familial Polyposis?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/39273517",
        "http://www.ncbi.nlm.nih.gov/pubmed/31936524",
        "http://www.ncbi.nlm.nih.gov/pubmed/35628659",
        "http://www.ncbi.nlm.nih.gov/pubmed/36232726",
        "http://www.ncbi.nlm.nih.gov/pubmed/37628632",
        "http://www.ncbi.nlm.nih.gov/pubmed/35327996",
        "http://www.ncbi.nlm.nih.gov/pubmed/34458603",
        "http://www.ncbi.nlm.nih.gov/pubmed/36153662",
        "http://www.ncbi.nlm.nih.gov/pubmed/34013567",
        "http://www.ncbi.nlm.nih.gov/pubmed/22059643"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39273517",
          "text": "Mucopolysaccharidosis-Plus Syndrome: Is This a Type of Mucopolysaccharidosis or a Separate Kind of Metabolic Disease?. Several years ago, dozens of cases were described in patients with symptoms very similar to mucopolysaccharidosis (MPS). This ne...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8091615438461304,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31936524",
          "text": "Mucopolysaccharidosis-Plus Syndrome.. Previously, we reported a novel disease of impaired glycosaminoglycans (GAGs) metabolism without deficiency of known lysosomal enzymes-mucopolysaccharidosis-plus syndrome (MPSPS). MPSPS, whose pathophysiology ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7941834926605225,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35628659",
          "text": "Hematopoietic Disorders, Renal Impairment and Growth in Mucopolysaccharidosis-Plus Syndrome.. Mucopolysaccharidoses (MPS) are rare lysosomal storage disorders (LSD) characterized by the excessive accumulation of glycosaminoglycans (GAG). Conventio...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7359826564788818,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36232726",
          "text": "Mucopolysaccharidosis-Plus Syndrome: Report on a Polish Patient with a Novel VPS33A Variant with Comparison with Other Described Patients.. Eleven patients from Yakutia with a new lysosomal disease assumed then as mucopolysaccharidosis-plus syndro...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6746305227279663,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37628632",
          "text": "Prenatal Diagnosis of Mucopolysaccharidosis-Plus Syndrome (MPSPS).. Mucopolysaccharidosis-plus syndrome (MPSPS) is an autosomal-recessive disorder caused by c.1492C>T (p.R498W) in the VPS33A gene. MPSPS is a severe disorder that causes a short lif...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6057066917419434,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35327996",
          "text": "Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child.. Mucopolysaccharidosis-plus syndrome (MPS-PS) is a novel autosomal recessive disorder cau...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5878417491912842,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34458603",
          "text": "Long-term evolution of mucopolysaccharidosis type I in twins treated with enzyme replacement therapy plus hematopoietic stem cells transplantation.. Mucopolysaccharidoses (MPSs) are a heterogeneous group of diseases that have in common the accumul...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5745353698730469,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36153662",
          "text": "Juvenile mucopolysaccharidosis plus disease caused by a missense mutation in VPS33A.. A rare and fatal disease resembling mucopolysaccharidosis in infants, is caused by impaired intracellular endocytic trafficking due to deficiency of core compone...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5436272621154785,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34013567",
          "text": "Homozygous missense VPS16 variant is associated with a novel disease, resembling mucopolysaccharidosis-plus syndrome in two siblings.. Disorders of intracellular trafficking are a group of inherited disorders, which often display multisystem pheno...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5251377820968628,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22059643",
          "text": "Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease.. UNLABELLED: Mucopolysaccharidosis type II (MPS II) is a rare, life-limiting, X-linked recessive disease characterised by...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5163271427154541,
          "rerank_position": 10
        }
      ],
      "id": "67c7708481b1027333000002",
      "type": "yesno",
      "body": "Is mucopolysaccharidosis-plus syndrome (MPSPS) a X-linked disease?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/2408143",
        "http://www.ncbi.nlm.nih.gov/pubmed/18900564",
        "http://www.ncbi.nlm.nih.gov/pubmed/964850",
        "http://www.ncbi.nlm.nih.gov/pubmed/19110959",
        "http://www.ncbi.nlm.nih.gov/pubmed/1297591",
        "http://www.ncbi.nlm.nih.gov/pubmed/2056934",
        "http://www.ncbi.nlm.nih.gov/pubmed/9254565",
        "http://www.ncbi.nlm.nih.gov/pubmed/29205981",
        "http://www.ncbi.nlm.nih.gov/pubmed/2068495",
        "http://www.ncbi.nlm.nih.gov/pubmed/3406636"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2408143",
          "text": "[Indications for cesarean section].. Following introductory remarks on rates of cesarean section, the relative and absolute indications for the procedure are reviewed. The rise in the rate of cesarean sections is due to widening of the relative in...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8396786451339722,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18900564",
          "text": "[Indication for Caesarean section delivery].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 44,
          "rerank_score": 0.8283356428146362,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/964850",
          "text": "[Indications for vital and preventive cesarean section].. The indications for Caesarean section have not only increased but also changed. A spectrum of indications is described which comprises emergency and preventive indications. The postpartal s...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7633955478668213,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19110959",
          "text": "[Caesarean section--indication or choice?].. Currently, caesarean section is the most commonly indicated procedure. The proportion of caesarean deliveries continues to rise. And the spectrum of surgical indications has dramatically broadened. This...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7418533563613892,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1297591",
          "text": "[Cesarean section: descriptive epidemiology. Increase in frequency of indications for cesarean section].. The use of caesarean section is constantly increasing in all countries of the western world. This article considers various aspects of the ph...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.729985237121582,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2056934",
          "text": "Cesarean section: science or ritual surgery?. Cesarean section has proven to be a powerful weapon in saving fetal and maternal life when scientific criteria are used in a variety of emergency conditions. However, because of the high incidence of f...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7238005995750427,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9254565",
          "text": "[The relationship between the outcome of a free vaginal birth and the indications for a prior cesarean section].. The author sets up the task to analyse the correlation between the results of vaginal delivery and the indications for a previous Cae...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.721627950668335,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29205981",
          "text": "Pregnancy and delivery after a cesarean section.. One out of seven of all parturients and one out of five primigravid women deliver by caesarean section. Of four women having undergone caesarean section, three will give birth vaginally, provided t...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7171387672424316,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2068495",
          "text": "[How to reduce the number of cesareans in teaching hospitals?].. The authors analyze their indications for cesareans for the year 1989, stressing the possibility of doing fewer. They carry out a critical analysis of the various indications by comp...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7048854827880859,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3406636",
          "text": "[Vaginal cesarean sections].. Vaginal caesarean section, or Durhssen's procedure, is seldom performed in France. Although its indications are exceptional, it enables to rapidly deliver a small fetus minimal maternal trauma without compromising the...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6989395618438721,
          "rerank_position": 10
        }
      ],
      "id": "67d7201b18b1e36f2e00002c",
      "type": "list",
      "body": "Indications of cesarean section."
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/32753671",
        "http://www.ncbi.nlm.nih.gov/pubmed/38183207",
        "http://www.ncbi.nlm.nih.gov/pubmed/33024276",
        "http://www.ncbi.nlm.nih.gov/pubmed/15675960",
        "http://www.ncbi.nlm.nih.gov/pubmed/22537248",
        "http://www.ncbi.nlm.nih.gov/pubmed/25865119",
        "http://www.ncbi.nlm.nih.gov/pubmed/28060736",
        "http://www.ncbi.nlm.nih.gov/pubmed/22536322",
        "http://www.ncbi.nlm.nih.gov/pubmed/27102072",
        "http://www.ncbi.nlm.nih.gov/pubmed/29995873"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32753671",
          "text": "Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma.. Melanoma cells can switch between a melanocytic and a mesenchymal-like state. Scattered evidence indicates that additional intermediate state(s) m...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5885539054870605,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38183207",
          "text": "Systematic analysis of the transcriptional landscape of melanoma reveals drug-target expression plasticity.. Metastatic melanoma originates from melanocytes of the skin. Melanoma metastasis results in poor treatment prognosis for patients and is a...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5856679677963257,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33024276",
          "text": "Transcriptional regulators and alterations that drive melanoma initiation and progression.. Although melanoma is the least frequent type of skin cancer, it accounts for the majority of skin cancer-related deaths. Large-scale sequencing efforts hav...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5510215163230896,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15675960",
          "text": "Gene expression profile changes between melanoma metastases and their daughter cell lines: implication for vaccination protocols.. Vaccination protocols based on autologous tumor material often require in vitro culturing of tumor cells to obtain e...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5379408001899719,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22537248",
          "text": "The stable traits of melanoma genetics: an alternate approach to target discovery.. BACKGROUND: The weight that gene copy number plays in transcription remains controversial; although in specific cases gene expression correlates with copy number, ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5377668738365173,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25865119",
          "text": "Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state.. Transcriptional reprogramming of proliferative melanoma cells into a phenotypically distinct invasive cell subpopulation is a critical event at ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5367882251739502,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060736",
          "text": "Investigating the utility of human melanoma cell lines as tumour models.. Melanoma researchers utilize cell lines to model many tumour phenomena. It is thus important to understand similarities and differences between cell lines and the tumours th...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5326594710350037,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22536322",
          "text": "Cell cycle gene networks are associated with melanoma prognosis.. BACKGROUND: Our understanding of the molecular pathways that underlie melanoma remains incomplete. Although several published microarray studies of clinical melanomas have provided ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5206563472747803,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27102072",
          "text": "Single-Cell RNA-Seq Reveals Melanoma Transcriptional Heterogeneity.. Single-cell analyses of 4,645 cells in multiple cell types reveal metastatic melanoma ecosystem.",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 165,
          "rerank_score": 0.5204540491104126,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29995873",
          "text": "RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas.. Recent studies revealed trajectories of mutational events in early melanomagenesis, but the accompanying changes in gene expression ar...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.510606050491333,
          "rerank_position": 10
        }
      ],
      "id": "67da148418b1e36f2e000054",
      "type": "list",
      "body": "What are the main transcriptional cell states found in melanoma?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/39180335",
        "http://www.ncbi.nlm.nih.gov/pubmed/36394232",
        "http://www.ncbi.nlm.nih.gov/pubmed/35275561",
        "http://www.ncbi.nlm.nih.gov/pubmed/35655148",
        "http://www.ncbi.nlm.nih.gov/pubmed/33486066",
        "http://www.ncbi.nlm.nih.gov/pubmed/33454728",
        "http://www.ncbi.nlm.nih.gov/pubmed/33722806",
        "http://www.ncbi.nlm.nih.gov/pubmed/37156393",
        "http://www.ncbi.nlm.nih.gov/pubmed/34087174",
        "http://www.ncbi.nlm.nih.gov/pubmed/33339524"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39180335",
          "text": "BioASQ Synergy: a dialogue between question-answering systems and biomedical experts for promoting COVID-19 research.. OBJECTIVE: This article presents the novel BioASQ Synergy research process which aims to facilitate the interaction between biom...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6922954320907593,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36394232",
          "text": "Epidemic Question Answering: question generation and entailment for Answer Nugget discovery.. OBJECTIVE: The rapidly growing body of communications during the COVID-19 pandemic posed a challenge to information seekers, who struggled to find answer...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6565056443214417,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35275561",
          "text": "Viruses without borders and the medical research agenda.. The COVID-19 pandemic has shown us that there are numerous research questions-empirical, political, and philosophical-that need addressing both prior to, during, and after a pandemic. The c...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.574092447757721,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35655148",
          "text": "CoQUAD: a COVID-19 question answering dataset system, facilitating research, benchmarking, and practice.. BACKGROUND: Due to the growing amount of COVID-19 research literature, medical experts, clinical scientists, and researchers frequently strug...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5659122467041016,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33486066",
          "text": "Making science computable: Developing code systems for statistics, study design, and risk of bias.. The COVID-19 crisis led a group of scientific and informatics experts to accelerate development of an infrastructure for electronic data exchange f...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.536357581615448,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33454728",
          "text": "Health informatics and EHR to support clinical research in the COVID-19 pandemic: an overview.. The coronavirus disease 2019 (COVID-19) pandemic has clearly shown that major challenges and threats for humankind need to be addressed with global ans...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5077093243598938,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33722806",
          "text": "Covid-19 driven advances in automation and artificial intelligence risk exacerbating economic inequality.. Anton Korinek and Joseph E Stiglitz make the case for a deliberate effort to steer technological advances in a direction that enhances the r...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5063393712043762,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37156393",
          "text": "Lessons learned to enable question answering on knowledge graphs extracted from scientific publications: A case study on the coronavirus literature.. The article presents a workflow to create a question-answering system whose knowledge base combin...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4997639060020447,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34087174",
          "text": "Rising to the challenge of COVID-19: Working on SARS-CoV-2 during the pandemic.. COVID-19 altered our lives and pushed scientific research to operate at breakneck speed, leading to significant breakthroughs in record time. We asked experts in the ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4987478256225586,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33339524",
          "text": "Health research system resilience: lesson learned from the COVID-19 crisis.. Producing evidence in epidemics is crucial to control the current epidemic and prevent its recurrence in the future. Data must be collected and analyzed rapidly to recogn...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4913094639778137,
          "rerank_position": 10
        }
      ],
      "id": "67d3434d18b1e36f2e000002",
      "type": "factoid",
      "body": "Which biomedical challenge has been designed to facilitate interaction between biomedical experts and automated question-answering systems in order to promote COVID-19 research?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/32544547",
        "http://www.ncbi.nlm.nih.gov/pubmed/27249100",
        "http://www.ncbi.nlm.nih.gov/pubmed/32278880",
        "http://www.ncbi.nlm.nih.gov/pubmed/27487107",
        "http://www.ncbi.nlm.nih.gov/pubmed/29550155",
        "http://www.ncbi.nlm.nih.gov/pubmed/34645590",
        "http://www.ncbi.nlm.nih.gov/pubmed/30614483",
        "http://www.ncbi.nlm.nih.gov/pubmed/33362177",
        "http://www.ncbi.nlm.nih.gov/pubmed/27568360",
        "http://www.ncbi.nlm.nih.gov/pubmed/31361848"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32544547",
          "text": "Trifluridine/tipiracil in earlier lines of chemotherapy for advanced colorectal cancer.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 87,
          "rerank_score": 0.6277632713317871,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27249100",
          "text": "In brief: trifluridine/tipiracil (Lonsurf) for metastatic colorectal cancer.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 76,
          "rerank_score": 0.598044216632843,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32278880",
          "text": "Neutropenia in metastatic colorectal cancer receiving trifluridine/tipiracil.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 77,
          "rerank_score": 0.5895998477935791,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27487107",
          "text": "Trifluridine/tipiracil and regorafenib: new weapons in the war against metastatic colorectal cancer.. Colorectal cancer (CRC) is the second leading cause of cancer-related death in the United States. Approximately 20% of patients have metastatic d...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5889028310775757,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29550155",
          "text": "Regorafenib or Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer? A Perspective on the Basis of Pharmacological Costs.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 134,
          "rerank_score": 0.5859975218772888,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34645590",
          "text": "Standard-Dose Trifluridine/Tipiracil as Safe Treatment Alternative in Metastatic Colorectal Cancer Patients With DPD Deficiency.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 128,
          "rerank_score": 0.5633969306945801,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30614483",
          "text": "Trifluridine/tipiracil in metastatic gastric cancer.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 52,
          "rerank_score": 0.5629057288169861,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33362177",
          "text": "Trifluridine/tipiracil or regorafenib in refractory metastatic colorectal cancer: from clinical trials to daily clinical practice.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 130,
          "rerank_score": 0.5620613098144531,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27568360",
          "text": "Trifluridine/Tipiracil: A Review in Metastatic Colorectal Cancer.. Trifluridine/tipiracil (Lonsurf(Â®)) is a novel, orally active, antimetabolite agent comprised of trifluridine, a thymidine-based nucleoside analogue, and tipiracil, a potent thymid...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5593630075454712,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31361848",
          "text": "The safety and efficacy of trifluridine-tipiracil for metastatic colorectal cancer: A pharmacy perspective.. PURPOSE: The pharmacology, pharmacokinetics, clinical efficacy, safety, dosing, and place in therapy of trifluridine-tipiracil are reviewe...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5516393184661865,
          "rerank_position": 10
        }
      ],
      "id": "662fc6aa187cba990d000017",
      "type": "summary",
      "body": "Why is Trifluridine/Tipiracil more active than other fluorpyrimidines in colorectal cancer patients?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/157971",
        "http://www.ncbi.nlm.nih.gov/pubmed/9141389",
        "http://www.ncbi.nlm.nih.gov/pubmed/90756",
        "http://www.ncbi.nlm.nih.gov/pubmed/34180",
        "http://www.ncbi.nlm.nih.gov/pubmed/21982424",
        "http://www.ncbi.nlm.nih.gov/pubmed/8880865",
        "http://www.ncbi.nlm.nih.gov/pubmed/16918231"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/157971",
          "text": "Evidence for a correlation between late replication and autosomal gene inactivation in a familial translocation t(X;21).. A familial translocation t(X;21)(q2700;q11) is studied. A girl, trisomic for almost all the chromosome 21, has a mildly abnor...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5168178081512451,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9141389",
          "text": "A molecular, clinical, and immunohistochemical study of vestibular schwannoma.. The molecular pathogenesis of vestibular schwannoma has been investigated by determining the extent of chromosome 22 loss of heterozygosity in 77 tumors and relating t...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.21750670671463013,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/90756",
          "text": "Age-dependent variability of ribosomal RNA-gene activity in man as determined from frequencies of silver staining nucleolus organizing regions on metaphase chromosomes of lymphocytes and fibroblasts.. Frequencies of silver staining nucleolus organ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.18800660967826843,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34180",
          "text": "The constitutive heterochromatin in chromosomes of Fritillaria Sp., as revealed by Giemsa banding.. The incidence of C-bands (constitutive heterochromatin), as determined by differential Giemsa staining, was studied in the chromosomes of 56 specie...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.17172329127788544,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21982424",
          "text": "High dimensional endophenotype ranking in the search for major depression risk genes.. BACKGROUND: Despite overwhelming evidence that major depression is highly heritable, recent studies have localized only a single depression-related locus reachi...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.14964765310287476,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8880865",
          "text": "Neurofibromatosis and associated tumour suppressor genes.. Neurofibromatosis 1 and 2 (NF1 and NF2) are autosomal dominantly inherited disorders with close to 100% penetrance. NF1 is one of the most frequent human genetic diseases with an incidence...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.11688016355037689,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16918231",
          "text": "Molecular biology of the primitive neuroectodermal tumor: a review.. In terms of its molecular biology and molecular genetics, medulloblastoma is the most thoroughly studied of the pediatric brain tumors. Alterations in chromosome 17, usually an i...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.09840372204780579,
          "rerank_position": 7
        }
      ],
      "id": "67cc89fa81b102733300000c",
      "type": "yesno",
      "body": "Is the inactivation of the X chromsome linked to cognition?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/37097782",
        "http://www.ncbi.nlm.nih.gov/pubmed/25948651",
        "http://www.ncbi.nlm.nih.gov/pubmed/18592027",
        "http://www.ncbi.nlm.nih.gov/pubmed/8766446",
        "http://www.ncbi.nlm.nih.gov/pubmed/12833829",
        "http://www.ncbi.nlm.nih.gov/pubmed/12117624",
        "http://www.ncbi.nlm.nih.gov/pubmed/28778107",
        "http://www.ncbi.nlm.nih.gov/pubmed/35451057",
        "http://www.ncbi.nlm.nih.gov/pubmed/12892987",
        "http://www.ncbi.nlm.nih.gov/pubmed/24547609"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37097782",
          "text": "Premenstrual dysphoric disorder.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 32,
          "rerank_score": 0.9035243988037109,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25948651",
          "text": "High prevalence of menstrual migraine comorbidity in patients with premenstrual dysphoric disorder: Retrospective survey.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 121,
          "rerank_score": 0.7885491847991943,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18592027",
          "text": "Premenstrual dysphoric disorder: burden of illness and treatment update.. Five percent of menstruating women have severe premenstrual symptoms and impairment of functioning defined as premenstrual dysphoric disorder (PMDD). Clinically significant ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7862367630004883,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8766446",
          "text": "[Premenstrual dysphoric disorder: an epidemiological study].. Most women have symptoms of premenstrual dysphoric disorder (PDD) and 3-10% have symptoms that interfere with either work or social life. The diagnosis of PDD is based on recurrent and ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7848141193389893,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12833829",
          "text": "Management of premenstrual dysphoric disorder.. Premenstrual dysphoric disorder is a complex disorder characterized by severe physical and psychological symptoms. The pathophysiology and effective treatment of premenstrual dysphoric disorder are p...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7830044627189636,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12117624",
          "text": "Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles.. BACKGROUND: Consistent data on the prevalence and predictors of premenstrual dysphoric disorder (PMDD) in the...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7799819707870483,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28778107",
          "text": "[Current Aspects of Premenstrual Dysphoric Disorder - A Review].. This narrative review presents current aspects of diagnosis, epidemiology, aetiology and therapy of Premenstrual Dysphoric Disorder (PMDD). PMDD is characterised by emotional, physi...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7786152958869934,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35451057",
          "text": "Premenstrual dysphoric disorder: A controversial new diagnosis.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 63,
          "rerank_score": 0.7779475450515747,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12892987",
          "text": "The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD).. Currently it is estimated that 3-8% of women of reproductive age meet strict criteria for premenstrual dysphoric disorder (PMDD). Assessment of publishe...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7753859758377075,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24547609",
          "text": "Depression, irritability, and anxiety in women with premenstrual dysphoric disorder.. OBJECTIVE: Depression, anxiety, and irritability are the three most studied symptoms of premenstrual dysphoric disorder (PMDD). This study aimed to assess the pr...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7753192186355591,
          "rerank_position": 10
        }
      ],
      "id": "67d4354518b1e36f2e000010",
      "type": "factoid",
      "body": "Prevalence of Premenstrual Dysphoric Disorder"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/15223831",
        "http://www.ncbi.nlm.nih.gov/pubmed/11042222",
        "http://www.ncbi.nlm.nih.gov/pubmed/18174356",
        "http://www.ncbi.nlm.nih.gov/pubmed/30348673",
        "http://www.ncbi.nlm.nih.gov/pubmed/11558676",
        "http://www.ncbi.nlm.nih.gov/pubmed/18027572",
        "http://www.ncbi.nlm.nih.gov/pubmed/8321207",
        "http://www.ncbi.nlm.nih.gov/pubmed/2017177",
        "http://www.ncbi.nlm.nih.gov/pubmed/15837526",
        "http://www.ncbi.nlm.nih.gov/pubmed/23428586"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15223831",
          "text": "Role of the GATA family of transcription factors in andrology.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 62,
          "rerank_score": 0.7775148153305054,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042222",
          "text": "The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 138,
          "rerank_score": 0.7329776287078857,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18174356",
          "text": "Role of the GATA family of transcription factors in endocrine development, function, and disease.. The WGATAR motif is a common nucleotide sequence found in the transcriptional regulatory regions of numerous genes. In vertebrates, these motifs are...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7092928886413574,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30348673",
          "text": "GATA transcription factors in development and disease.. The GATA family of transcription factors is of crucial importance during embryonic development, playing complex and widespread roles in cell fate decisions and tissue morphogenesis. GATA prot...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.68699049949646,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11558676",
          "text": "Regulation of the ANF and BNP promoters by GATA factors: lessons learned for cardiac transcription.. The identification and molecular cloning of the cardiac transcription factors GATA-4, -5, and -6 has greatly contributed to our understanding of h...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6605379581451416,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18027572",
          "text": "[Function and gene expression regulation of GATA-1 and GATA-2 transcription].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 77,
          "rerank_score": 0.6488725543022156,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8321207",
          "text": "DNA-binding specificity of GATA family transcription factors.. GATA-binding proteins constitute a family of transcription factors that recognize a target site conforming to the consensus WGATAR (W = A or T and R = A or G). Here we have used the me...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6448705792427063,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2017177",
          "text": "Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer.. A family of transcriptional activators has recently been identified in chickens; these trans...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6430788040161133,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15837526",
          "text": "GATA factors and transcriptional regulation of cardiac natriuretic peptide genes.. The A- and B-natriuretic peptides (ANP and BNP) are the heart major secretory products. ANF and BNP expression is a marker of cardiomyocyte differentiation, and is ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6391886472702026,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23428586",
          "text": "Expression and potential role of GATA factors in trophoblast development.. Despite exhaustive studies, molecular mechanisms governing blastocyst formation, implantation to the uterine endometrium and placentation have not been definitively charact...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6389422416687012,
          "rerank_position": 10
        }
      ],
      "id": "67d74a9b18b1e36f2e00003a",
      "type": "yesno",
      "body": "Are transcription factors of the GATA family found in the brain?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/34400559",
        "http://www.ncbi.nlm.nih.gov/pubmed/25305004",
        "http://www.ncbi.nlm.nih.gov/pubmed/19631309",
        "http://www.ncbi.nlm.nih.gov/pubmed/39298702",
        "http://www.ncbi.nlm.nih.gov/pubmed/34433720",
        "http://www.ncbi.nlm.nih.gov/pubmed/31361628",
        "http://www.ncbi.nlm.nih.gov/pubmed/32221959",
        "http://www.ncbi.nlm.nih.gov/pubmed/30291185",
        "http://www.ncbi.nlm.nih.gov/pubmed/23452772",
        "http://www.ncbi.nlm.nih.gov/pubmed/33390901"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34400559",
          "text": "Myasthenia gravis genome-wide association study implicates AGRN as a risk locus.. BACKGROUND: Myasthenia gravis (MG) is a rare autoimmune disorder affecting the neuromuscular junction (NMJ). Here, we investigate the genetic architecture of MG via ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4810921251773834,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25305004",
          "text": "Inherited disorders of the neuromuscular junction: an update.. Congenital myasthenic syndromes (CMSs) are a group of heterogeneous inherited disorders caused by mutations in genes affecting the function and structure of the neuromuscular junction....",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.40408849716186523,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19631309",
          "text": "Identification of an agrin mutation that causes congenital myasthenia and affects synapse function.. We report the case of a congenital myasthenic syndrome due to a mutation in AGRN, the gene encoding agrin, an extracellular matrix molecule releas...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.38939815759658813,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39298702",
          "text": "Teaching Video NeuroImage: Remarkable Improvement of AGRN-Associated Congenital Myasthenia Weakness After Salbutamol Use.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 121,
          "rerank_score": 0.37639203667640686,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34433720",
          "text": "Novel LG1 Mutations in Agrin Causing Congenital Myasthenia Syndrome.. The patient had suffered from both proximal and distal limb weakness since her early childhood, without the involvement of ocular or respiratory muscles. Repetitive nerve stimul...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.36604011058807373,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31361628",
          "text": "The congenital myasthenic syndromes: expanding genetic and phenotypic spectrums and refining treatment strategies.. PURPOSE OF REVIEW: Congenital myasthenic syndromes (CMS) are a group of heterogeneous inherited disorders caused by mutations in ge...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.3480786681175232,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32221959",
          "text": "AGRN Gene Mutation Leads to Congenital Myasthenia Syndromes: A Pediatric Case Report and Literature Review.. The congenital myasthenia syndromes (CMS) are a group of autosomal recessive or autosomal dominant diseases that affect neuromuscular junc...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.34672343730926514,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30291185",
          "text": "Congenital myasthenic syndromes in adult neurology clinic: A long road to diagnosis and therapy.. OBJECTIVE: To investigate the diagnostic challenges of congenital myasthenic syndromes (CMS) in adult neuromuscular practice. METHODS: We searched th...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.3313319981098175,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23452772",
          "text": "[Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy--The French National Congenital Myasthenic Syndrome Network experience].. Congenital myasthenic syndromes (CMS) are a heterogeneous group of disorde...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.3239421248435974,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33390901",
          "text": "Modulation of the Acetylcholine Receptor Clustering Pathway Improves Neuromuscular Junction Structure and Muscle Strength in a Mouse Model of Congenital Myasthenic Syndrome.. Introduction: Congenital myasthenic syndromes (CMS) are a diverse group ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.3184470236301422,
          "rerank_position": 10
        }
      ],
      "id": "67d41b8518b1e36f2e00000d",
      "type": "yesno",
      "body": "Is there any role between AGRN and Myasthenia gravis?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/13719442",
        "http://www.ncbi.nlm.nih.gov/pubmed/18906865",
        "http://www.ncbi.nlm.nih.gov/pubmed/33487841",
        "http://www.ncbi.nlm.nih.gov/pubmed/22366241",
        "http://www.ncbi.nlm.nih.gov/pubmed/13794248",
        "http://www.ncbi.nlm.nih.gov/pubmed/5607175",
        "http://www.ncbi.nlm.nih.gov/pubmed/5829514",
        "http://www.ncbi.nlm.nih.gov/pubmed/23865149",
        "http://www.ncbi.nlm.nih.gov/pubmed/28511925",
        "http://www.ncbi.nlm.nih.gov/pubmed/36135798"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/13719442",
          "text": "[Primary modifications of the repolarization phase in congenital heart diseases. Note 3. Tetrology of Fallot and Eisenmenger's complex].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 136,
          "rerank_score": 0.5007163286209106,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18906865",
          "text": "Congenital heart disease; tetralogy of Fallot.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 46,
          "rerank_score": 0.430073082447052,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33487841",
          "text": "Uncorrected Tetralogy of Fallot's: Anesthetic Challenges.. Tetrology of Fallot's (TOF) is the most common cause of cyanotic congenital heart disease, and accounts for 10% of all congenital heart diseases. Right to left shunting and hyperviscosity ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.39845338463783264,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22366241",
          "text": "An infant with spinal muscular atrophy and tetrology of Fallot.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 63,
          "rerank_score": 0.3833671808242798,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/13794248",
          "text": "[The pathological anatomy of the Vieussens-Rhebesius vessels in dextroposition of the bulbus of the heart (tetrology of Fallot) and their role in coronary circulation in this disease].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 184,
          "rerank_score": 0.3800315260887146,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/5607175",
          "text": "[On the state of oxidative processes during tetrology of Fallot in early childhood before and after the establishment of intervascular anastomoses].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 148,
          "rerank_score": 0.3693365454673767,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/5829514",
          "text": "A case of dextroversion of the heart with tetrology of Fallot and left sided aortic arch.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 89,
          "rerank_score": 0.3610202670097351,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23865149",
          "text": "Anaesthetic management of craniotomy for intracranial lesion in a child with uncorrected tetrology of fallot.. The case of a 16 years old female with uncorrected Tetrology of Fallot, who operated for intracranial lesion in parieto frontal area wit...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.34566885232925415,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28511925",
          "text": "Total Correction of Tetralogy of Fallot at Early Age: A Study of 183 Cases.. BACKGROUND: Opinions regarding the optimal time for the repair of tetralogy of Fallot vary. A debate also exists about the timing of repair for the asymptomatic infant. M...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.33512309193611145,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36135798",
          "text": "Commentary: native technique versus patch and enlargement techniques in tetralogy of Fallot with hypoplastic branch pulmonary arteries.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 135,
          "rerank_score": 0.32490965723991394,
          "rerank_position": 10
        }
      ],
      "id": "67cdbe0c81b1027333000019",
      "type": "list",
      "body": "Please list the 4 problems that are found in the tetrology of Fallot."
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/8135682",
        "http://www.ncbi.nlm.nih.gov/pubmed/11377748",
        "http://www.ncbi.nlm.nih.gov/pubmed/17239033",
        "http://www.ncbi.nlm.nih.gov/pubmed/11122915",
        "http://www.ncbi.nlm.nih.gov/pubmed/14978466",
        "http://www.ncbi.nlm.nih.gov/pubmed/11843778",
        "http://www.ncbi.nlm.nih.gov/pubmed/15597133",
        "http://www.ncbi.nlm.nih.gov/pubmed/18221632",
        "http://www.ncbi.nlm.nih.gov/pubmed/8811161",
        "http://www.ncbi.nlm.nih.gov/pubmed/27725659"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8135682",
          "text": "The genetics of bipolar disorder.. Growing interest in the application of molecular biological techniques to psychiatric disorders has reinvigorated interest in the genetics of the psychoses. It is therefore timely to review the current state of k...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6645655632019043,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11377748",
          "text": "Molecular genetics of bipolar disorder.. Alteration of monoaminergic neurotransmission is implicated in the pathophysiology of bipolar disorder (manic-depressive illness). Candidate genes participating in monoaminergic neurotransmission, especiall...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6619721055030823,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17239033",
          "text": "Molecular genetics of bipolar disorder and depression.. In this review, all papers relevant to the molecular genetics of bipolar disorder published from 2004 to the present (mid 2006) are reviewed, and major results on depression are summarized. S...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6547055244445801,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11122915",
          "text": "Recent progress in the search for genes for bipolar disorder.. Over many decades, much evidence has been accumulated to demonstrate the strong role of genetic factors in bipolar disorder. Recently, genetic studies of bipolar disorder have turned f...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6431704759597778,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14978466",
          "text": "Genetic linkage in bipolar disorder.. Bipolar disorder is an etiologically complex syndrome that is clearly heritable. Multiple genes, working singly or in concert, are likely to cause susceptibility to bipolar disorder. Bipolar disorder genetics ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6380113959312439,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11843778",
          "text": "Molecular linkage studies of bipolar disorders.. OBJECTIVES: To review the reports of linkage findings for bipolar disorder. METHODS: Literature review of published linkage findings in bipolar disorder. RESULTS: There are several regions of the hu...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6280630230903625,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15597133",
          "text": "[Genetics of bipolar disorder].. Bipolar disorder (BD) is a worldwide highly prevalent mental disease. This disorder has a genetic inheritance characterized by complex transmission mechanisms involving multiple genes. Many investigation strategies...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6246136426925659,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18221632",
          "text": "Genetics of bipolar disorder.. Family and twin studies have consistently documented that bipolar disorder (BPD) is familial and heritable, but efforts to identify specific susceptibility genes have been complicated by the disorder's genetic and ph...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6172529458999634,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8811161",
          "text": "Molecular genetics of bipolar disorder.. Bipolar (BP) disorder is a severe mood disorder affecting about 1% of the population. Even though the traditional twin, family, and adoption studies have demonstrated that it is highly heritable, the specif...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6165933609008789,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27725659",
          "text": "Rare deleterious mutations are associated with disease in bipolar disorder families.. Bipolar disorder (BD) is a common, complex and heritable psychiatric disorder characterized by episodes of severe mood swings. The identification of rare, damagi...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.609693169593811,
          "rerank_position": 10
        }
      ],
      "id": "67d7238518b1e36f2e000038",
      "type": "summary",
      "body": "Regarding genetic transmission of bipolar disorder, has any specific gene/mutation been identified?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/29387965",
        "http://www.ncbi.nlm.nih.gov/pubmed/23131159",
        "http://www.ncbi.nlm.nih.gov/pubmed/26559096",
        "http://www.ncbi.nlm.nih.gov/pubmed/20309962",
        "http://www.ncbi.nlm.nih.gov/pubmed/20021464",
        "http://www.ncbi.nlm.nih.gov/pubmed/39609830",
        "http://www.ncbi.nlm.nih.gov/pubmed/26559087",
        "http://www.ncbi.nlm.nih.gov/pubmed/17921733",
        "http://www.ncbi.nlm.nih.gov/pubmed/24642524",
        "http://www.ncbi.nlm.nih.gov/pubmed/20064612"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29387965",
          "text": "Cell biology of glioblastoma multiforme: from basic science to diagnosis and treatment.. First described in the 1800s, glioblastoma multiforme (GBM), a class IV neoplasm with astrocytic differentiation, as per the revised 2016 World Health Organiz...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6600878238677979,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23131159",
          "text": "Angiogenesis and hypoxia in glioblastoma: a focus on cancer stem cells.. Many studies have elucidated the important role played by the tumor microenvironment in cancer evolution. In particular the formation of hypoxic areas within the expanding ma...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6558830738067627,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26559096",
          "text": "Hypoxia Is the Driving Force Behind GBM and Could Be a New Tool in GBM Treatment.. Glioblastoma (GBM) can be divided into two distinct disease entities according to the genetic and the epigenetic background of the tumor. Tumor location is associat...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6399927139282227,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20309962",
          "text": "Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma.. Glioblastoma multiforme (GBM) are highly proliferative tumors currently treated by surgical removal, followed by radiotherapy and chemotherapy, whic...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6396986842155457,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20021464",
          "text": "Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy.. Glioblastoma Multiforme (GBM) tumors are the most common type of brain tumors. These tumors are in general very malignant and can be characterized as rapi...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.631755530834198,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39609830",
          "text": "The neglected burden of chronic hypoxia on the resistance of glioblastoma multiforme to first-line therapies.. Glioblastoma multiforme (GBM) is the most common adult primary brain tumor. The standard of care involves maximal surgery followed by ra...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6279244422912598,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26559087",
          "text": "Glioblastoma Multiforme: The Genetic Perspective of the Treatment Planning.. Glioblastoma multiforme (GBM) is divided into two distinct disease entities called primary and secondary GBM. The genetic and the epigenetic background of these tumors ar...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6259022355079651,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17921733",
          "text": "Mechanisms operative in the antitumor activity of temozolomide in glioblastoma multiforme.. PURPOSE: Glioblastoma multiforme (GBM) is the most frequent and incurable brain tumor in adults. Although temozolomide (TMZ) does not cure GBM, it has demo...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6049686074256897,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24642524",
          "text": "GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity.. Gliomas are a heterogeneous group of tumors that show variable proliferative potential, invasiveness, aggressiveness, histological grading, and clinical beh...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6017627716064453,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20064612",
          "text": "The DNA methylome of glioblastoma multiforme.. Glioblastoma multiforme (GBM) is the most frequent brain tumor in adults. This lethal cancer is a challenge in neuro-oncology since patients almost invariably succumb to the disease. Intensive molecul...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.595099925994873,
          "rerank_position": 10
        }
      ],
      "id": "67d74b0418b1e36f2e00003b",
      "type": "summary",
      "body": "How does hypoxia influence the cell states of glioblastoma multiforme (GBM)?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/37962376",
        "http://www.ncbi.nlm.nih.gov/pubmed/24194598",
        "http://www.ncbi.nlm.nih.gov/pubmed/31701148",
        "http://www.ncbi.nlm.nih.gov/pubmed/26531826",
        "http://www.ncbi.nlm.nih.gov/pubmed/18006571",
        "http://www.ncbi.nlm.nih.gov/pubmed/19906716",
        "http://www.ncbi.nlm.nih.gov/pubmed/34850907",
        "http://www.ncbi.nlm.nih.gov/pubmed/16381983",
        "http://www.ncbi.nlm.nih.gov/pubmed/38480866",
        "http://www.ncbi.nlm.nih.gov/pubmed/29161433"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37962376",
          "text": "JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles.. JASPAR (https://jaspar.elixir.no/) is a widely-used open-access database presenting manually curated high-quality and non-redundant DNA-binding pr...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.47676461935043335,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24194598",
          "text": "JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles.. JASPAR (http://jaspar.genereg.net) is the largest open-access database of matrix-based nucleotide profiles describing the binding pref...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4379878342151642,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31701148",
          "text": "JASPAR 2020: update of the open-access database of transcription factor binding profiles.. JASPAR (http://jaspar.genereg.net) is an open-access database of curated, non-redundant transcription factor (TF)-binding profiles stored as position freque...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.42894667387008667,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26531826",
          "text": "JASPAR 2016: a major expansion and update of the open-access database of transcription factor binding profiles.. JASPAR (http://jaspar.genereg.net) is an open-access database storing curated, non-redundant transcription factor (TF) binding profile...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.41883140802383423,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18006571",
          "text": "JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update.. JASPAR is a popular open-access database for matrix models describing DNA-binding preferences for transcription factors and other...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.41626691818237305,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19906716",
          "text": "JASPAR 2010: the greatly expanded open-access database of transcription factor binding profiles.. JASPAR (http://jaspar.genereg.net) is the leading open-access database of matrix profiles describing the DNA-binding patterns of transcription factor...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4081549048423767,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34850907",
          "text": "JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles.. JASPAR (http://jaspar.genereg.net/) is an open-access database containing manually curated, non-redundant transcription factor (TF) binding profile...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.40795665979385376,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16381983",
          "text": "A new generation of JASPAR, the open-access repository for transcription factor binding site profiles.. JASPAR is the most complete open-access collection of transcription factor binding site (TFBS) matrices. In this new release, JASPAR grows into...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.40607941150665283,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38480866",
          "text": "Author Correction: In vivo marker of brainstem myelin is associated to quantitative sleep parameters in healthy young men.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 122,
          "rerank_score": 0.39419692754745483,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29161433",
          "text": "JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 111,
          "rerank_score": 0.38276660442352295,
          "rerank_position": 10
        }
      ],
      "id": "67d496ed18b1e36f2e000019",
      "type": "factoid",
      "body": "What's the increase in CORE profiles in JASPAR 2024 compared to the previous version?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/41080",
        "http://www.ncbi.nlm.nih.gov/pubmed/1966568",
        "http://www.ncbi.nlm.nih.gov/pubmed/231227",
        "http://www.ncbi.nlm.nih.gov/pubmed/24893275",
        "http://www.ncbi.nlm.nih.gov/pubmed/32436697",
        "http://www.ncbi.nlm.nih.gov/pubmed/15557845",
        "http://www.ncbi.nlm.nih.gov/pubmed/731481",
        "http://www.ncbi.nlm.nih.gov/pubmed/7339768",
        "http://www.ncbi.nlm.nih.gov/pubmed/211462",
        "http://www.ncbi.nlm.nih.gov/pubmed/7852758"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/41080",
          "text": "Which pharmacological action of baclofen matters most?",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 54,
          "rerank_score": 0.7075133323669434,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1966568",
          "text": "Is the antispastic action of baclofen mediated by GABAB receptors? GABAB receptors and spasticity.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 98,
          "rerank_score": 0.6120995283126831,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/231227",
          "text": "Pharmacology of (+)- and (-)-baclofen: GABA-dependant rotational behaviour and [3H]GABA receptor binding studies.. (+)- and (-)-baclofen were equiactive in inducing contralateral rotational behaviour following their unilateral injection into the z...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5580806136131287,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24893275",
          "text": "Clinical relevance of pharmacological and physiological data in intrathecal baclofen therapy.. OBJECTIVE: To review all pharmacological and physiological data available on intrathecal baclofen (ITB) therapy and to evaluate its use in clinical prac...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5465950965881348,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32436697",
          "text": "Classics in Chemical Neuroscience: Baclofen.. Baclofen, Î²-(4-chlorophenyl)-Î³-aminobutyric acid, holds a unique position in neuroscience, remaining the only U.S. Food and Drug Administration (FDA) approved GABAB agonist. While intended to be a more...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5408560633659363,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15557845",
          "text": "Does general anesthesia potentiate the GABA-ergic action of intrathecal baclofen?",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 81,
          "rerank_score": 0.5401893854141235,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/731481",
          "text": "Central depressant action of baclofen [proceedings].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 52,
          "rerank_score": 0.5321959853172302,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7339768",
          "text": "[Neurophysiologic tests of the antispasmodic action of baclofen].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 65,
          "rerank_score": 0.5279765725135803,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/211462",
          "text": "Action of baclofen on mammalian synaptic transmission.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 54,
          "rerank_score": 0.526503324508667,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7852758",
          "text": "Baclofen as an adjuvant analgesic.. Baclofen is a gamma-aminobutyric acid (GABA) agonist approved for the treatment of spasticity and commonly used in the management of many types of neuropathic pain. Controlled studies have demonstrated the effic...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5218352675437927,
          "rerank_position": 10
        }
      ],
      "id": "67cdca3881b102733300001b",
      "type": "summary",
      "body": "What is the mode of action for baclofen?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/550448",
        "http://www.ncbi.nlm.nih.gov/pubmed/12132453",
        "http://www.ncbi.nlm.nih.gov/pubmed/32146997",
        "http://www.ncbi.nlm.nih.gov/pubmed/10173308",
        "http://www.ncbi.nlm.nih.gov/pubmed/24024392",
        "http://www.ncbi.nlm.nih.gov/pubmed/18536788",
        "http://www.ncbi.nlm.nih.gov/pubmed/24502087",
        "http://www.ncbi.nlm.nih.gov/pubmed/29809381",
        "http://www.ncbi.nlm.nih.gov/pubmed/11045134",
        "http://www.ncbi.nlm.nih.gov/pubmed/7246909"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/550448",
          "text": "Side-effects of metformin.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 26,
          "rerank_score": 0.8874756097793579,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12132453",
          "text": "Side effects. Metformin--caution and concerns.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 46,
          "rerank_score": 0.7523385882377625,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32146997",
          "text": "Toxicity of Metformin and Hypoglycemic Therapies.. Metformin along with other antidiabetic medications provide benefit to patients in the treatment of type 2 diabetes mellitus, but caution is advised in certain scenarios to avoid toxicity in kidne...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7276343107223511,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10173308",
          "text": "Managing therapy and adverse effects with antihyperglycemic agents: a focus on metformin and acarbose.. Metformin and acarbose are novel antihyperglycemic agents indicated for the treatment of non-insulin-dependent diabetes mellitus. These agents ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7049266695976257,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24024392",
          "text": "[Toxicity of metformin, pro- or con- a future restriction to its contraindications?].. Type 2 diabetes, a world-wide epidemic, is a major concern of health systems around the world. The recommandation of its early management with metformin by the ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6703492403030396,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18536788",
          "text": "Metformin: a review.. Metformin is a well-established ingredient of diabetes management, both as a monotherapy in early stages of type 2 diabetes and as adjunct therapy to virtually every other antihyperglycemic medicine available today. Despite l...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6263154745101929,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24502087",
          "text": "Metformin induced lactic acidosis--particularities and course.. Diabetes mellitus is a widespread disease with many serious chronic complications. An improvement in the oral antidiabetic medication in respect to its mechanism of action and toxicol...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6233862638473511,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29809381",
          "text": "An Evidence Based Study on Comparison of Adverse Drug Reactions of Metformin & Sitagliptin with their Combination.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 114,
          "rerank_score": 0.6192459464073181,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11045134",
          "text": "[Metformin efficacious in poorly controlled diabetes mellitus type 2].. Three patients, 1 man and 2 women, aged 60, 55 and 72 years, had an insufficient glucose regulation with insulin therapy or with sulfonylurea derivatives. They started metform...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6166553497314453,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7246909",
          "text": "[Lactic acidosis associated with metformin treatment. Discussion of the responsibility of the drug].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 100,
          "rerank_score": 0.6041243076324463,
          "rerank_position": 10
        }
      ],
      "id": "67d6bf9a18b1e36f2e000023",
      "type": "list",
      "body": "Adverse effects of metformin."
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/29387965",
        "http://www.ncbi.nlm.nih.gov/pubmed/29946775",
        "http://www.ncbi.nlm.nih.gov/pubmed/21429292",
        "http://www.ncbi.nlm.nih.gov/pubmed/28582760",
        "http://www.ncbi.nlm.nih.gov/pubmed/25312641",
        "http://www.ncbi.nlm.nih.gov/pubmed/29668458",
        "http://www.ncbi.nlm.nih.gov/pubmed/38782497",
        "http://www.ncbi.nlm.nih.gov/pubmed/20531430",
        "http://www.ncbi.nlm.nih.gov/pubmed/25985640",
        "http://www.ncbi.nlm.nih.gov/pubmed/20064612"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29387965",
          "text": "Cell biology of glioblastoma multiforme: from basic science to diagnosis and treatment.. First described in the 1800s, glioblastoma multiforme (GBM), a class IV neoplasm with astrocytic differentiation, as per the revised 2016 World Health Organiz...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7804462313652039,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29946775",
          "text": "The Multifaceted Metabolism of Glioblastoma.. Glioblastoma multiforme (GBM) develops on glial cells and is the most common, as well as the deadliest, form of brain cancer [1]. As in pancreatic cancers, distinct combinations of genetic alterations ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7314333319664001,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21429292",
          "text": "Glioblastoma multiforme: a perspective on recent findings in human cancer and mouse models.. Gliomas are the most frequently occurring primary malignancies in the central nervous system, and glioblastoma multiforme (GBM) is the most common and mos...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6995388865470886,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28582760",
          "text": "Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review.. Glioblastoma multiforme (GBM) is the deadliest form of heterogeneous brain cancer. It affects an enormous number of patients every year and the...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6944820880889893,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25312641",
          "text": "Emerging treatment strategies for glioblastoma multiforme.. Glioblastoma multiforme (GBM) is the deadliest form of brain tumor with a more than 90% 5-year mortality. GBM has a paltry median survival of 12.6Â months attributed to the unique treatmen...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6925276517868042,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29668458",
          "text": "On the Concepts and History of Glioblastoma Multiforme - Morphology, Genetics and Epigenetics.. Glioblastoma multiforme (GBM) is a grade IV WHO malignant tumor with astrocytic differentiation. As one of the most common clinically diagnosed central...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6864588260650635,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38782497",
          "text": "Cellular signaling in glioblastoma: A molecular and clinical perspective.. Glioblastoma multiforme (GBM) is the most aggressive brain tumor with an average life expectancy of less than 15 months. Such high patient mortality in GBM is pertaining to...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6692399978637695,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20531430",
          "text": "Neuro-oncology: unmasking the multiforme in glioblastoma.. Classification of glioblastomas into various molecular entities is required for the successful application of targeted therapeutics and personalized cancer therapy. Analyses of gene expres...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6666020750999451,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25985640",
          "text": "[Brain tumor stem cells].. Glioblastoma multiforme (GBM) is the most frequent and aggressive brain tumor, and which harbors not only rapidly dividing cells but also small populations of slowly dividing and dormant cells with tumorigenesity-, self-...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.659366250038147,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20064612",
          "text": "The DNA methylome of glioblastoma multiforme.. Glioblastoma multiforme (GBM) is the most frequent brain tumor in adults. This lethal cancer is a challenge in neuro-oncology since patients almost invariably succumb to the disease. Intensive molecul...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6590650081634521,
          "rerank_position": 10
        }
      ],
      "id": "67c7392981b1027333000001",
      "type": "list",
      "body": "What are the main cell states of glioblastoma multiforme (GBM)?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/35921524",
        "http://www.ncbi.nlm.nih.gov/pubmed/33547427",
        "http://www.ncbi.nlm.nih.gov/pubmed/32195191",
        "http://www.ncbi.nlm.nih.gov/pubmed/31594837",
        "http://www.ncbi.nlm.nih.gov/pubmed/23699655",
        "http://www.ncbi.nlm.nih.gov/pubmed/31185210",
        "http://www.ncbi.nlm.nih.gov/pubmed/19500427",
        "http://www.ncbi.nlm.nih.gov/pubmed/34622231",
        "http://www.ncbi.nlm.nih.gov/pubmed/36635566",
        "http://www.ncbi.nlm.nih.gov/pubmed/27196765"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35921524",
          "text": "Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance.. PURPOSE: PARP inhibitors (PARPi) induce synthetic lethality in homologous recombinati...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5665557384490967,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33547427",
          "text": "WEE1 inhibition after platinum resistance.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 42,
          "rerank_score": 0.5625147819519043,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32195191",
          "text": "Increased HDAC Activity and c-MYC Expression Mediate Acquired Resistance to WEE1 Inhibition in Acute Leukemia.. WEE1 is a cell cycle and DNA damage response kinase that is emerging as a therapeutic target for cancer. AZD1775 is a small molecule in...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5440387725830078,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31594837",
          "text": "Upregulation of Myt1 Promotes Acquired Resistance of Cancer Cells to Wee1 Inhibition.. Adavosertib (also known as AZD1775 or MK1775) is a small-molecule inhibitor of the protein kinase Wee1, with single-agent activity in multiple solid tumors, inc...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5363119840621948,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23699655",
          "text": "Preclinical evaluation of the WEE1 inhibitor MK-1775 as single-agent anticancer therapy.. Inhibition of the DNA damage checkpoint kinase WEE1 potentiates genotoxic chemotherapies by abrogating cell-cycle arrest and proper DNA repair. However, WEE1...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5170832276344299,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31185210",
          "text": "Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy.. We demonstrate that concurrent administration of poly(ADP-ribose) polymerase (PARP) and WEE1 inhibitors is effective in inhibiting tumor growth but po...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5149946808815002,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19500427",
          "text": "Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor.. BACKGROUND: Wee1 is a tyrosine kinase regulating S-G2 cell cycle transition through the inactivating phosphorylation of CDC2. ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5122882723808289,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34622231",
          "text": "CCNE1 copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models.. CCNE1-amplified ovarian cancers (OVCAs) and endometrial cancers (EMCAs) are associated with platinum resistance and poor su...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5089809894561768,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36635566",
          "text": "SIRT1 deacetylates WEE1 and sensitizes cancer cells to WEE1 inhibition.. The cell-cycle checkpoint kinase WEE1 is emerging as a therapeutic target for cancer treatment. However, how its catalytic activity is regulated remains poorly understood, an...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5054826736450195,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27196765",
          "text": "PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer.. The DNA damage response (DDR) involves a complex network of signaling events mediated by modular protein domains such as the BRCA1 C-terminal (BRCT) ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.49533167481422424,
          "rerank_position": 10
        }
      ],
      "id": "67d34ad518b1e36f2e000005",
      "type": "yesno",
      "body": "Is high WEE1 expression linked to PARP inhibition resistance?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/2355139",
        "http://www.ncbi.nlm.nih.gov/pubmed/39628433",
        "http://www.ncbi.nlm.nih.gov/pubmed/31756690",
        "http://www.ncbi.nlm.nih.gov/pubmed/2229541",
        "http://www.ncbi.nlm.nih.gov/pubmed/22093235",
        "http://www.ncbi.nlm.nih.gov/pubmed/32884618",
        "http://www.ncbi.nlm.nih.gov/pubmed/39015395",
        "http://www.ncbi.nlm.nih.gov/pubmed/39825948",
        "http://www.ncbi.nlm.nih.gov/pubmed/10319838",
        "http://www.ncbi.nlm.nih.gov/pubmed/29687064"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2355139",
          "text": "Pilomatrix carcinoma.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 21,
          "rerank_score": 0.5776432752609253,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39628433",
          "text": "Surgical treatment of pilomatrix carcinoma: a systematic review.. Pilomatrix carcinoma (PMC), also known as pilomatrical carcinoma, is a rare, malignant tumor of the hair follicle that may arise from a benign pilomatricoma or de novo and carries a...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.562645435333252,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31756690",
          "text": "Pilomatrix carcinoma of the right postauricular region: A case report and literature review.. INTRODUCTION: Pilomatrix carcinoma is a rare aggressive tumor with a high rate of local recurrence after surgical excision. Diagnosis is made by histopat...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5550568103790283,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2229541",
          "text": "Giant pilomatrix carcinoma: report and review of the literature.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 64,
          "rerank_score": 0.5531206130981445,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22093235",
          "text": "Management of pilomatrix carcinoma: a case report of successful treatment with Mohs micrographic surgery and review of the literature.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 134,
          "rerank_score": 0.5527268052101135,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32884618",
          "text": "Not Your Average Skin Cancer: A Rare Case of Pilomatrix Carcinoma.. Pilomatrix carcinoma is a rare malignancy stemming from aberrant proliferation of matrical cells found in developing hair. This neoplasm demonstrates a bimodal age distribution an...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5478789210319519,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39015395",
          "text": "Pilomatrix Carcinoma: A Benign-Mimic with Malignant Consequences - A Case Report and Review of the Current Literature.. INTRODUCTION: Pilomatrix carcinomas (PMXCs) are uncommon, locally aggressive tumors with high recurrence rates, metastatic pote...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5448850393295288,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39825948",
          "text": "Pilomatrix carcinoma unveiled: a systematic review of clinical characteristics, pathogenesis, diagnostic puzzles, and management strategies.. Pilomatrix carcinoma (PC) is a rare malignant adnexal tumor originating from follicular matrix cells prim...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5380216836929321,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10319838",
          "text": "Pilomatrix carcinoma of the face.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 33,
          "rerank_score": 0.5287175178527832,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29687064",
          "text": "Facial pilomatrix carcinomas treated with Mohs micrographic surgery.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 68,
          "rerank_score": 0.5239775776863098,
          "rerank_position": 10
        }
      ],
      "id": "67cc9e6381b1027333000016",
      "type": "list",
      "body": "Please list the surgical treatments for Pilomatrix carcinoma."
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/18069294",
        "http://www.ncbi.nlm.nih.gov/pubmed/9707855",
        "http://www.ncbi.nlm.nih.gov/pubmed/4745119",
        "http://www.ncbi.nlm.nih.gov/pubmed/10901853",
        "http://www.ncbi.nlm.nih.gov/pubmed/34957305",
        "http://www.ncbi.nlm.nih.gov/pubmed/17803458",
        "http://www.ncbi.nlm.nih.gov/pubmed/14195513",
        "http://www.ncbi.nlm.nih.gov/pubmed/1565556",
        "http://www.ncbi.nlm.nih.gov/pubmed/26601449",
        "http://www.ncbi.nlm.nih.gov/pubmed/32443524"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18069294",
          "text": "[Mosquito-vector infections: Dengue fever].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 43,
          "rerank_score": 0.8836761713027954,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9707855",
          "text": "Dengue viral infection.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 23,
          "rerank_score": 0.8207663297653198,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/4745119",
          "text": "Dengue.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 7,
          "rerank_score": 0.7639263868331909,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10901853",
          "text": "Comments on the epidemiology, pathogenesis and control of dengue.. Dengue is currently the most important viral disease transmitted to man by arthropods, whether measured by the number of cases or number of deaths. Prevalence of the disease is hig...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7615073919296265,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34957305",
          "text": "Production, Transmission, Pathogenesis, and Control of Dengue Virus: A Literature-Based Undivided Perspective.. Dengue remains one of the most serious and widespread mosquito-borne viral infections in human beings, with serious health problems or ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7515857219696045,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17803458",
          "text": "Dengue virus-mosquito interactions.. The mosquito Aedes aegypti is more widely dispersed now than at any time in the past, placing billions of humans at risk of infection with one or more of the four dengue viruses. This review presents and discus...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7439910173416138,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14195513",
          "text": "VECTORS OF DENGUE AND CHIKUNGUNYA VIRUSES: A BRIEF REVIEW.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 58,
          "rerank_score": 0.7334249019622803,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1565556",
          "text": "Dengue and dengue hemorrhagic fever.. Hundreds of thousands of dengue cases are reported worldwide each year. Given the difficulty in obtaining full reporting, the actual number of human infections is probably much higher than the number reported....",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.732416033744812,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26601449",
          "text": "Dengue and other flavivirus infections.. Flaviviruses are responsible for yellow fever, Zika fever and dengue, all of which are major human diseases found in tropical regions of the globe. They are zoonoses with a transmission cycle that involves ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7276622653007507,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32443524",
          "text": "Administration of Defective Virus Inhibits Dengue Transmission into Mosquitoes.. The host-vector shuttle and the bottleneck in dengue transmission is a significant aspect with regard to the study of dengue outbreaks. As mosquitoes require 100-1000...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.710594654083252,
          "rerank_position": 10
        }
      ],
      "id": "67d7fe1718b1e36f2e000043",
      "type": "factoid",
      "body": "Vector of dengue infection."
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/39701039",
        "http://www.ncbi.nlm.nih.gov/pubmed/27041580",
        "http://www.ncbi.nlm.nih.gov/pubmed/36637349",
        "http://www.ncbi.nlm.nih.gov/pubmed/20655317",
        "http://www.ncbi.nlm.nih.gov/pubmed/33862619",
        "http://www.ncbi.nlm.nih.gov/pubmed/34152549",
        "http://www.ncbi.nlm.nih.gov/pubmed/38876751",
        "http://www.ncbi.nlm.nih.gov/pubmed/23607282",
        "http://www.ncbi.nlm.nih.gov/pubmed/38244080",
        "http://www.ncbi.nlm.nih.gov/pubmed/36539501"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39701039",
          "text": "Give me a sign(ature): Converging on the CSC of glioblastoma.. The identification of stem cells in glioblastomas has been controversial. In this issue of Neuron, Xie etÂ al.1 establish gene signatures for cellular states and a quiescent cancer stem...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6348060965538025,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27041580",
          "text": "A comprehensive profile of recurrent glioblastoma.. In spite of relentless efforts to devise new treatment strategies, primary glioblastomas invariably recur as aggressive, therapy-resistant relapses and patients rapidly succumb to these tumors. M...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5951319932937622,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36637349",
          "text": "Phenotype Switching in Glioblastoma Promotes Therapy Escape.. A shift to a mesenchymal phenotype characterizes recurrence in glioblastoma and is mediated by AP1.",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 161,
          "rerank_score": 0.5722618103027344,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20655317",
          "text": "A hypothesis and theoretical model speculating the possible role of therapy mediated neoplastic cell loss in promoting the process of glioblastoma relapse.. Tumor recurrence is considered to be one of the biggest culprits, behind the poor prognosi...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5659931898117065,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33862619",
          "text": "Re-evaluating Biopsy for Recurrent Glioblastoma: A Position Statement by the Christopher Davidson Forum Investigators.. Patients with glioblastoma (GBM) need bold new approaches to their treatment, yet progress has been hindered by a relative inab...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5246439576148987,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34152549",
          "text": "The inverse paradigm and the ancestral cell of IDH-wildtype glioblastoma.. Rethinking IDH-wildtype glioblastoma through its unique features can help researchers find innovative and effective treatments. It is currently emerging that, after decades...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5132098197937012,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38876751",
          "text": "Glioblastoma and brain connectivity: the need for a paradigm shift.. Despite substantial advances in cancer treatment, for patients with glioblastoma prognosis remains bleak. The emerging field of cancer neuroscience reveals intricate functional i...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.509337306022644,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23607282",
          "text": "Therapeutic strategies targeting glioblastoma stem cells.. Glioblastoma is the most common, aggressive and lethal brain tumor in adults. However, current therapeutic protocols have low success rates and average overall survival is less than 15 mon...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5035231113433838,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38244080",
          "text": "Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.. The longitudinal transition of phenotypes is pivotal in glioblastoma treatment resistanceÂ and DNA methylation emerged as an important tool f...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.502989649772644,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36539501",
          "text": "A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets.. Recent longitudinal studies of glioblastoma (GBM) have demonstrated a lack of apparent selection pressure for specific DNA ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.49508732557296753,
          "rerank_position": 10
        }
      ],
      "id": "67da131f18b1e36f2e000053",
      "type": "yesno",
      "body": "Is there a shift in the cell states of glioblastoma during recurrence?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/31770575",
        "http://www.ncbi.nlm.nih.gov/pubmed/23114252",
        "http://www.ncbi.nlm.nih.gov/pubmed/21355061",
        "http://www.ncbi.nlm.nih.gov/pubmed/36926036",
        "http://www.ncbi.nlm.nih.gov/pubmed/30547231",
        "http://www.ncbi.nlm.nih.gov/pubmed/30557881",
        "http://www.ncbi.nlm.nih.gov/pubmed/24052458",
        "http://www.ncbi.nlm.nih.gov/pubmed/32379818",
        "http://www.ncbi.nlm.nih.gov/pubmed/21781439",
        "http://www.ncbi.nlm.nih.gov/pubmed/27197912"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31770575",
          "text": "Association between CUBN gene variants, type 2 diabetes and vitamin D concentrations in an elderly Greek population.. Accumulating evidence suggests a potential implication of vitamin D biological network in the pathogenesis of diabetes mellitus. ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5135708451271057,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23114252",
          "text": "Linkage disequilibrium analysis reveals an albuminuria risk haplotype containing three missense mutations in the cubilin gene with striking differences among European and African ancestry populations.. BACKGROUND: A recent meta-analysis described ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4864037036895752,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21355061",
          "text": "CUBN is a gene locus for albuminuria.. Identification of genetic risk factors for albuminuria may alter strategies for early prevention of CKD progression, particularly among patients with diabetes. Little is known about the influence of common ge...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4834890067577362,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36926036",
          "text": "Four missense genetic variants in CUBN are associated with higher levels of eGFR in non-diabetes but not in diabetes mellitus or its subtypes: A genetic association study in Europeans.. AIM: Rare genetic variants in the CUBN gene encoding the main...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4714471399784088,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30547231",
          "text": "A novel rare CUBN variant and three additional genes identified in Europeans with and without diabetes: results from an exome-wide association study of albuminuria.. AIMS/HYPOTHESIS: Identifying rare coding variants associated with albuminuria may...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.469533771276474,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30557881",
          "text": "Cubilin Single Nucleotide Polymorphism Variants are Associated with Macroangiopathy While a Matrix Metalloproteinase-9 Single Nucleotide Polymorphism Flip-Flop may Indicate Susceptibility of Diabetic Nephropathy in Type-2 Diabetic Patients.. AIM: ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4338225722312927,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24052458",
          "text": "The association of a single-nucleotide polymorphism in CUBN and the risk of albuminuria and cardiovascular disease.. BACKGROUND: Albuminuria is an important risk factor for cardiovascular disease (CVD). We have previously identified a missense sin...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4277023673057556,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32379818",
          "text": "Smoking-by-genotype interaction in type 2 diabetes risk and fasting glucose.. Smoking is a potentially causal behavioral risk factor for type 2 diabetes (T2D), but not all smokers develop T2D. It is unknown whether genetic factors partially explai...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.41515982151031494,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21781439",
          "text": "No association between polymorphisms in cubilin, a gene of the homocysteine metabolism and the risk of non-syndromic cleft lip with or without cleft palate.. Epidemiological studies have correlated lower maternal periconceptional levels of plasma ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.41022711992263794,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27197912",
          "text": "Association Analysis of the Cubilin (CUBN) and Megalin (LRP2) Genes with ESRD in African Americans.. BACKGROUND AND OBJECTIVES: Genetic variation in the cubilin (CUBN) gene is associated with albuminuria and CKD. Common and rare coding variants in...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.39759182929992676,
          "rerank_position": 10
        }
      ],
      "id": "67d45d5818b1e36f2e000012",
      "type": "factoid",
      "body": "In which population has it been described an association between the CUBN gene and T2DM genetic susceptibility?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/12004654",
        "http://www.ncbi.nlm.nih.gov/pubmed/2267544",
        "http://www.ncbi.nlm.nih.gov/pubmed/39060406",
        "http://www.ncbi.nlm.nih.gov/pubmed/23335219",
        "http://www.ncbi.nlm.nih.gov/pubmed/27189896",
        "http://www.ncbi.nlm.nih.gov/pubmed/3393117",
        "http://www.ncbi.nlm.nih.gov/pubmed/8113521",
        "http://www.ncbi.nlm.nih.gov/pubmed/21035563",
        "http://www.ncbi.nlm.nih.gov/pubmed/28366533",
        "http://www.ncbi.nlm.nih.gov/pubmed/20968105"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12004654",
          "text": "Artificial saliva products and drugs to treat xerostomia.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 57,
          "rerank_score": 0.5558034181594849,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2267544",
          "text": "Other hints for treating xerostomia.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 36,
          "rerank_score": 0.5543777346611023,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39060406",
          "text": "The use of stem cells in treating xerostomia: a systematic review.. INTRODUCTION: The complex nature of xerostomia prevents the establishment of a definite cure. Recently, research has pivoted towards stem cell transplantation for glandular recons...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5516880750656128,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23335219",
          "text": "Concise review: Adult salivary gland stem cells and a potential therapy for xerostomia.. The ability to speak, swallow, masticate, taste food, and maintain a healthy oral cavity is heavily reliant on the presence of saliva, the hugely important ef...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5457788705825806,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27189896",
          "text": "Xerostomia: current streams of investigation.. Xerostomia is the subjective feeling of dry mouth, and it is often related to salivary hypofunction. Besides medication-related salivary hypofunction, SjÃ¶gren syndrome and head-and-neck radiation are ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5143564939498901,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3393117",
          "text": "Treatment of xerostomia.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 24,
          "rerank_score": 0.4936237335205078,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8113521",
          "text": "Scientists find remedy for patients' suffering from post-irradiation xerostomia.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 80,
          "rerank_score": 0.49272170662879944,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21035563",
          "text": "Bone marrow-derived cells: A potential approach for the treatment of xerostomia.. Transplantations of bone marrow-derived cells (BMDCs) are traditionally used for hematologic diseases, but there are increasing numbers of clinical trials using BMDC...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.491449773311615,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28366533",
          "text": "[Xerostomia].. Xerostomia is a frequent complaint and a real handicap for many patients, often drug-induced. Treatments, even if they are currently unsatisfactory, are aimed at improved oral comfort and quality of life for patients, and to prevent...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.48925113677978516,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20968105",
          "text": "[Theses 25 years after date 23. Developments in the prevention and treatment of xerostomia].. Twenty-five years ago, the treatment of xerostomia was predominantly symptomatic. At that time, the treatment possibilities were mainly sialogogues, mout...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.48477745056152344,
          "rerank_position": 10
        }
      ],
      "id": "67cde99581b102733300001f",
      "type": "yesno",
      "body": "Can stem cell therapies be used to treat xerostomia"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/13727832",
        "http://www.ncbi.nlm.nih.gov/pubmed/6403828",
        "http://www.ncbi.nlm.nih.gov/pubmed/13727831",
        "http://www.ncbi.nlm.nih.gov/pubmed/14000652",
        "http://www.ncbi.nlm.nih.gov/pubmed/8412581",
        "http://www.ncbi.nlm.nih.gov/pubmed/14079856",
        "http://www.ncbi.nlm.nih.gov/pubmed/12319651",
        "http://www.ncbi.nlm.nih.gov/pubmed/14144360",
        "http://www.ncbi.nlm.nih.gov/pubmed/4988903",
        "http://www.ncbi.nlm.nih.gov/pubmed/14373884"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/13727832",
          "text": "[The problem of African trypanosomiasis].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 41,
          "rerank_score": 0.707206130027771,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/6403828",
          "text": "African trypanosomiasis.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 24,
          "rerank_score": 0.6809110045433044,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/13727831",
          "text": "A review of the African trypanosomiasis problem.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 48,
          "rerank_score": 0.679962158203125,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14000652",
          "text": "Trypanosomiasis. African trypanosomiasis.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 41,
          "rerank_score": 0.6728037595748901,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8412581",
          "text": "[From sleep observation to the discovery of trypanosomiasis and glossina].. The african human trypanosomiasis constitutes one of the fascinating subjects of research about the expansion of the European biomedical science. Its history shows the sci...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6615155339241028,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14079856",
          "text": "[THE REVIVESCENCE OF A FOCUS OF AFRICAN TRYPANOSOMIASIS].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 57,
          "rerank_score": 0.6565097570419312,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12319651",
          "text": "The scourge of human African trypanosomiasis.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 45,
          "rerank_score": 0.6470078229904175,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14144360",
          "text": "TRYPANOSOMIASIS.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 16,
          "rerank_score": 0.6424770355224609,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/4988903",
          "text": "Trypanosomiasis.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 16,
          "rerank_score": 0.6424770355224609,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14373884",
          "text": "TRYPANOSOMIASIS.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 16,
          "rerank_score": 0.6424770355224609,
          "rerank_position": 10
        }
      ],
      "id": "67d6bda918b1e36f2e000021",
      "type": "factoid",
      "body": "What is the cause of African trypanosomiasis?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/17085591",
        "http://www.ncbi.nlm.nih.gov/pubmed/9499579",
        "http://www.ncbi.nlm.nih.gov/pubmed/27421669",
        "http://www.ncbi.nlm.nih.gov/pubmed/28368398",
        "http://www.ncbi.nlm.nih.gov/pubmed/12565854",
        "http://www.ncbi.nlm.nih.gov/pubmed/23380592",
        "http://www.ncbi.nlm.nih.gov/pubmed/35389210",
        "http://www.ncbi.nlm.nih.gov/pubmed/15628970",
        "http://www.ncbi.nlm.nih.gov/pubmed/38396900",
        "http://www.ncbi.nlm.nih.gov/pubmed/28178271"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17085591",
          "text": "Insights into transcription enhancer factor 1 (TEF-1) activity from the solution structure of the TEA domain.. Transcription enhancer factor 1 is essential for cardiac, skeletal, and smooth muscle development and uses its N-terminal TEA domain (TE...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6703742742538452,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9499579",
          "text": "Regulation of gene expression at the beginning of mammalian development and the TEAD family of transcription factors.. In mouse development, transcription is first detected in late 1-cell embryos, but translation of newly synthesized transcripts d...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6586647629737854,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27421669",
          "text": "An evolutionary, structural and functional overview of the mammalian TEAD1 and TEAD2 transcription factors.. TEAD proteins constitute a family of highly conserved transcription factors, characterized by a DNA-binding domain called the TEA domain a...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.614420473575592,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368398",
          "text": "DNA-binding mechanism of the Hippo pathway transcription factor TEAD4.. TEA domain (TEAD) family transcription factors are key regulators in development, tissue homeostasis and cancer progression. TEAD4 acts as a critical downstream effector of th...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5872635841369629,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12565854",
          "text": "Inhibition of the TEF/TEAD transcription factor activity by nuclear calcium and distinct kinase pathways.. Transcription enhancer factor (TEF/TEAD) is a family of four transcription factors that share a common TEA-DNA binding domain and are involv...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5686688423156738,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23380592",
          "text": "Emerging roles of TEAD transcription factors and its coactivators in cancers.. TEAD proteins are transcription factors that are crucial for development, but also play a role in cancers. Several developmentally and pathologically important genes ar...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.549379289150238,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35389210",
          "text": "Toward the Design of Ligands Selective for the C-Terminal Domain of TEADs.. The Hippo signaling pathway plays a fundamental role in the control of organ growth, cell proliferation, and stem cell characters. TEADs are the main transcriptional outpu...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5372598171234131,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15628970",
          "text": "The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members.. Members of the highly related TEF-1 (transcriptional enhancer factor-1) family (also known as TEAD, for TEF-1, TEC1, ABAA...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5341541171073914,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38396900",
          "text": "Integrative Epigenetic and Molecular Analysis Reveals a Novel Promoter for a New Isoform of the Transcription Factor TEAD4.. TEAD4 is a transcription factor that plays a crucial role in the Hippo pathway by regulating the expression of genes relat...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5318459272384644,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28178271",
          "text": "TEAD transcription factors are required for normal primary myoblast differentiation in vitro and muscle regeneration in vivo.. The TEAD family of transcription factors (TEAD1-4) bind the MCAT element in the regulatory elements of both growth promo...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5226950645446777,
          "rerank_position": 10
        }
      ],
      "id": "67d7506e18b1e36f2e00003f",
      "type": "factoid",
      "body": "What is the consensus binding site of the TEAD transcription factors?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28716001",
        "http://www.ncbi.nlm.nih.gov/pubmed/31086968",
        "http://www.ncbi.nlm.nih.gov/pubmed/25861967",
        "http://www.ncbi.nlm.nih.gov/pubmed/35573078",
        "http://www.ncbi.nlm.nih.gov/pubmed/27708560"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28716001",
          "text": "Variant Ranker: a web-tool to rank genomic data according to functional significance.. BACKGROUND: The increasing volume and complexity of high-throughput genomic data make analysis and prioritization of variants difficult for researchers with lim...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.555014967918396,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31086968",
          "text": "Variant Score Ranker-a web application for intuitive missense variant prioritization.. MOTIVATION: The correct classification of missense variants as benign or pathogenic remains challenging. Pathogenic variants are expected to have higher deleter...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5075888633728027,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25861967",
          "text": "GeneTIER: prioritization of candidate disease genes using tissue-specific gene expression profiles.. MOTIVATION: In attempts to determine the genetic causes of human disease, researchers are often faced with a large number of candidate genes. Link...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.3346329927444458,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35573078",
          "text": "On cross-lingual retrieval with multilingual text encoders.. Pretrained multilingual text encoders based on neural transformer architectures, such as multilingual BERT (mBERT) and XLM, have recently become a default paradigm for cross-lingual tran...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.19428282976150513,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27708560",
          "text": "Targeted Re-Sequencing Approach of Candidate Genes Implicates Rare Potentially Functional Variants in Tourette Syndrome Etiology.. Although the genetic basis of Tourette Syndrome (TS) remains unclear, several candidate genes have been implicated. ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.17012840509414673,
          "rerank_position": 5
        }
      ],
      "id": "67d4854918b1e36f2e000014",
      "type": "summary",
      "body": "Describe Variant Ranker"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/25599729",
        "http://www.ncbi.nlm.nih.gov/pubmed/34187299",
        "http://www.ncbi.nlm.nih.gov/pubmed/1143136",
        "http://www.ncbi.nlm.nih.gov/pubmed/4855606",
        "http://www.ncbi.nlm.nih.gov/pubmed/3424872",
        "http://www.ncbi.nlm.nih.gov/pubmed/21196155",
        "http://www.ncbi.nlm.nih.gov/pubmed/6936639",
        "http://www.ncbi.nlm.nih.gov/pubmed/7923527",
        "http://www.ncbi.nlm.nih.gov/pubmed/17142653",
        "http://www.ncbi.nlm.nih.gov/pubmed/34811876"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25599729",
          "text": "Drug-induced acute interstitial nephritis: pathology, pathogenesis, and treatment.. Drug-induced acute interstitial nephritis (DAIN) is a common cause of acute kidney injury and often presents as an unexplained rise in serum creatinine level. Kidn...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.46947431564331055,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34187299",
          "text": "Prognosis of severe drug-induced acute interstitial nephritis requiring renal replacement therapy.. OBJECTIVE: Drug-induced acute interstitial nephritis (DAIN) is often associated with improved outcomes, whereas some patients may still progress to...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.3137947618961334,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1143136",
          "text": "Editorial: Le Dain Commission on Drugs.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 39,
          "rerank_score": 0.29969024658203125,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/4855606",
          "text": "Le Dain Commission of Inquiry into the Non-Medical Use of Drugs tables fourth and final report.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 95,
          "rerank_score": 0.2830166220664978,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3424872",
          "text": "Pharmacokinetics and metabolism of alpha-[(dimethylamino)methyl]-2- (3-ethyl-5-methyl-4-isoxazolyl)-1H-indole-3-methanol, a hypoglycemic agent, in man.. 1. The pharmacokinetics and metabolism of alpha-[(dimethylamino)methyl]-2-(3-ethyl-5-methyl-4-...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.2263333946466446,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21196155",
          "text": "L-arginine, NO and asymmetrical dimethylarginine in hypertension and type 2 diabetes.. Both hypertension and type 2 diabetes mellitus are common and there are no reliable markers either to predict their development or complications. High fat diet ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.22450651228427887,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/6936639",
          "text": "Intrauterine diagnosis of duodenal atresia.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 43,
          "rerank_score": 0.20820710062980652,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7923527",
          "text": "Drug labelling.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 15,
          "rerank_score": 0.19457247853279114,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17142653",
          "text": "Brief review: perioperative management of the patient with chronic non-cancer pain.. PURPOSE: Both opioid and non-opioid medications are being utilized increasingly in the treatment of chronic non-cancer pain, and the number of surgical patients r...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.18848758935928345,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34811876",
          "text": "Andexanet alfa for reversal of rivaroxaban in a child with intracranial hemorrhage.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 83,
          "rerank_score": 0.17968088388442993,
          "rerank_position": 10
        }
      ],
      "id": "67cec6e781b1027333000021",
      "type": "yesno",
      "body": "Is creatinine usually elevated in Drug-induced intestinal neuropathy(DAIN)?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/39447121",
        "http://www.ncbi.nlm.nih.gov/pubmed/25288080",
        "http://www.ncbi.nlm.nih.gov/pubmed/24397146",
        "http://www.ncbi.nlm.nih.gov/pubmed/27531828",
        "http://www.ncbi.nlm.nih.gov/pubmed/27641814",
        "http://www.ncbi.nlm.nih.gov/pubmed/29689301",
        "http://www.ncbi.nlm.nih.gov/pubmed/38096530",
        "http://www.ncbi.nlm.nih.gov/pubmed/29777176",
        "http://www.ncbi.nlm.nih.gov/pubmed/29616809",
        "http://www.ncbi.nlm.nih.gov/pubmed/39392836"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39447121",
          "text": "Expanding the Î²-Lactamase Family in the Human Microbiome.. Î²-lactams, the most common antibiotics globally, have resistance primarily determined by Î²-lactamases. Human microbiota and Î²-lactams influence mutually; however, Î²-lactamase variety and a...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5687491297721863,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25288080",
          "text": "Metallo-Î²-lactamase-producing bacteroides species can shield other members of the gut microbiota from antibiotics.. Antibiotics disrupt the intestinal microbiota, rendering patients vulnerable to colonization by exogenous pathogens. Intermicrobial...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5537034869194031,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24397146",
          "text": "[Human microbiomes--normal microbiota underlying a growing number of diseases].. Human microbiomes refer to complex bacterial communities colonizing the skin and the mucous membranes of various body cavities. Microbiomes and especially their aberr...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5148934125900269,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27531828",
          "text": "Antibiotics as deep modulators of gut microbiota: between good and evil.. The recent increase in our knowledge of human gut microbiota has changed our view on antibiotics. Antibiotics are, indeed, no longer considered only beneficial, but also pot...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.49297258257865906,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27641814",
          "text": "Antibiotic use and microbiome function.. Our microbiome should be understood as one of the most complex components of the human body. The use of Î²-lactam antibiotics is one of the microbiome covariates that influence its composition. The extent to...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4910759925842285,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29689301",
          "text": "Distinct consequences of amoxicillin and ertapenem exposure in the porcine gut microbiome.. The gut microbiome influences many, if not all, aspects of human health. Antibiotics, while lifesaving, have the unintended consequence of killing commensa...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4882376492023468,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38096530",
          "text": "UNDERSTANDING THE ADAPTATION AND SENSITIVITY OF THE MICROBIOME: MICROBIAL RESILIENT AND HUMAN WELL-BEING.. The term microbiome describes the assortment of microbes that dwell in and on a person's body, particularly in the gut, comprising fungi, ba...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4866749942302704,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29777176",
          "text": "Feasting on Î²-lactams.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 22,
          "rerank_score": 0.4856310784816742,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29616809",
          "text": "Î²-Lactam Biotransformations Activate Innate Immunity.. Antibiotics are widely prescribed to treat bacterial infections, but many of these drugs also affect patient immune responses. While the molecular mechanisms regulating these diverse immunomod...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4830936789512634,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39392836",
          "text": "Microbes as medicine.. Over the last two decades, advancements in sequencing technologies have significantly deepened our understanding of the human microbiome's complexity, leading to increased concerns about the detrimental effects of antibiotic...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4792235791683197,
          "rerank_position": 10
        }
      ],
      "id": "67d721d118b1e36f2e000031",
      "type": "yesno",
      "body": "Are systemic beta lactams considered harmful to the human microbiome?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/25103728",
        "http://www.ncbi.nlm.nih.gov/pubmed/20108752",
        "http://www.ncbi.nlm.nih.gov/pubmed/19324552",
        "http://www.ncbi.nlm.nih.gov/pubmed/33172155",
        "http://www.ncbi.nlm.nih.gov/pubmed/23777544",
        "http://www.ncbi.nlm.nih.gov/pubmed/20462843",
        "http://www.ncbi.nlm.nih.gov/pubmed/12826827",
        "http://www.ncbi.nlm.nih.gov/pubmed/9804374",
        "http://www.ncbi.nlm.nih.gov/pubmed/16540738",
        "http://www.ncbi.nlm.nih.gov/pubmed/28611289"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25103728",
          "text": "Whole genome sequencing of glioblastoma multiforme identifies multiple structural variations involved in EGFR activation.. Next generation sequencing has become a powerful tool in dissecting and identifying mutations and genomic structural variant...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6807066202163696,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20108752",
          "text": "Current data and strategy in glioblastoma multiforme.. Glioblastoma multiforme (GBM) or astrocytoma grade IV on WHO classification is the most aggressive and the most frequent of all primary brain tumors. Glioblastoma is multiforme, resistant to t...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6764792203903198,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19324552",
          "text": "The EGFRvIII variant in glioblastoma multiforme.. Glioblastoma multiforme (GBM) is the most common brain tumour and has the worst prognosis. Epidermal growth factor receptor (EGFR) gene amplification, mutation and re-arrangement (all of which enha...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6686229705810547,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33172155",
          "text": "Identification of New Genetic Clusters in Glioblastoma Multiforme: EGFR Status and ADD3 Losses Influence Prognosis.. Glioblastoma multiforme (GB) is one of the most aggressive tumors. Despite continuous efforts to improve its clinical management, ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6543288826942444,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23777544",
          "text": "The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered.. The epidermal growth factor receptor (EGFR) is overexpressed in a variety of human epithelial tumors, often as a consequence of gene amplification. Tumors...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6416172981262207,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20462843",
          "text": "Response to erlotinib in recurrent glioblastoma multiforme showing coexpression of EGFRvIII and PTEN.. Glioblastoma multiforme (GBM) is the most aggressive brain tumour in adults and remains incurable despite multimodal intensive treatment regimen...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6374664306640625,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12826827",
          "text": "Genetic markers in glioblastoma: prognostic significance and future therapeutic implications.. Glioblastoma multiforme (GBM) is the highest-grade infiltrative astrocytoma and also the most common. It is generally associated with a dismal prognosis...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6329150199890137,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9804374",
          "text": "Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes.. Deregulated expression of one or more growth control genes including p16, p53, EGF receptor (EGFR), MDM2 or Bcl-2 ma...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6313382387161255,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16540738",
          "text": "Epidermal growth factor receptor gene amplification and protein expression in glioblastoma multiforme: prognostic significance and relationship to other prognostic factors.. Epidermal growth factor receptor (EGFR) overexpression occurs in a signif...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6312859058380127,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28611289",
          "text": "Next generation sequencing and molecular imaging identify EGFR mutation and amplification in a glioblastoma multiforme patient treated with an EGFR inhibitor: a case report.. Epidermal growth factor receptor (EGFR) mutations and amplifications are...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6292576789855957,
          "rerank_position": 10
        }
      ],
      "id": "67da0c0f18b1e36f2e000052",
      "type": "factoid",
      "body": "What is the most common EGFR mutation in glioblastoma multiforme?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/19663136",
        "http://www.ncbi.nlm.nih.gov/pubmed/20592751",
        "http://www.ncbi.nlm.nih.gov/pubmed/19046748",
        "http://www.ncbi.nlm.nih.gov/pubmed/21104233",
        "http://www.ncbi.nlm.nih.gov/pubmed/29196930",
        "http://www.ncbi.nlm.nih.gov/pubmed/17520163",
        "http://www.ncbi.nlm.nih.gov/pubmed/23778325",
        "http://www.ncbi.nlm.nih.gov/pubmed/16598376",
        "http://www.ncbi.nlm.nih.gov/pubmed/26036173",
        "http://www.ncbi.nlm.nih.gov/pubmed/20061896"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19663136",
          "text": "Lack of association of ALOX12 and ALOX15 polymorphisms with aspirin-exacerbated respiratory disease in Korean patients.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 119,
          "rerank_score": 0.5748676657676697,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20592751",
          "text": "Human lipoxygenase pathway gene variation and association with markers of subclinical atherosclerosis in the diabetes heart study.. AIMS: Genes of the 5-lipoxygenase pathway are compelling candidates for atherosclerosis. We hypothesize that polymo...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5319281816482544,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19046748",
          "text": "Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke.. OBJECTIVES: Eicosanoids are lipid mediators that may play a role in atherosclerosis. We investigated the association of common genetic variation in prostaglandin ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5221567749977112,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21104233",
          "text": "Polymorphisms in the ALOX12 gene and osteoporosis.. UNLABELLED: ALOX12 produces ligands for PPARÎ³ thereby turning mesenchymal stem cells into adipocytes instead of osteoblasts. We investigated the effect of polymorphisms in the ALOX12 gene on BMD ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5195409059524536,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29196930",
          "text": "Association of ALOX12 gene polymorphism with all-cause and cardiovascular mortality in diabetic nephropathy.. PURPOSE: Cardiovascular (CV) events are the first cause of death in patients with chronic renal disease (CKD) and in patients with type 2...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5189908742904663,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17520163",
          "text": "Polymorphisms in ALOX12, but not ALOX15, are significantly associated with BMD in postmenopausal women.. The murine arachidonate 15-lipoxygenase gene (Alox15) has recently been identified as a negative regulator of peak bone mineral density (BMD)....",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5181201100349426,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23778325",
          "text": "Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: results from a pilot study.. OBJECTIVE: Chemoprevention trials have shown that celecoxib reduces adenoma recurrence but can cause cardiovascu...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4781956076622009,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16598376",
          "text": "Human ALOX12, but not ALOX15, is associated with BMD in white men and women.. UNLABELLED: The Alox15 gene was recently identified as a negative regulator of peak BMD in mice. Polymorphisms in human ALOX12, but not ALOX15, were significantly associ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.47776293754577637,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26036173",
          "text": "Polymorphisms in inflammation associated genes ALOX15 and IL-6 are associated with bone properties in young women and fracture in elderly.. PURPOSE: ALOX12 and ALOX15 encode arachidonate lipoxygenases which produce lipid metabolites involved in in...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.46736910939216614,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20061896",
          "text": "ALOX12 gene is associated with the onset of natural menopause in white women.. OBJECTIVE: Natural menopause is a key physiological event in a woman's life. Timing of menopause affects risk for many postmenopausal systemic disorders and may thus in...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.466858834028244,
          "rerank_position": 10
        }
      ],
      "id": "67d486e118b1e36f2e000015",
      "type": "list",
      "body": "Which cardiovascular events are associated with ALOX12 gene polymorphisms?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/8718319",
        "http://www.ncbi.nlm.nih.gov/pubmed/9451117",
        "http://www.ncbi.nlm.nih.gov/pubmed/10232201",
        "http://www.ncbi.nlm.nih.gov/pubmed/17651232",
        "http://www.ncbi.nlm.nih.gov/pubmed/10246189",
        "http://www.ncbi.nlm.nih.gov/pubmed/7724638",
        "http://www.ncbi.nlm.nih.gov/pubmed/4680909",
        "http://www.ncbi.nlm.nih.gov/pubmed/11061705",
        "http://www.ncbi.nlm.nih.gov/pubmed/7950536",
        "http://www.ncbi.nlm.nih.gov/pubmed/11010701"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8718319",
          "text": "Dressings available on the Drug Tariff.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 39,
          "rerank_score": 0.4232342839241028,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9451117",
          "text": "Choosing a dressing from the drug tariff.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 41,
          "rerank_score": 0.4072459936141968,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10232201",
          "text": "Wound dressings and the Drug Tariff.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 36,
          "rerank_score": 0.4007816016674042,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17651232",
          "text": "The safety and efficacy of dressings with silver - addressing clinical concerns.. With the increasing use of silver as a topical application in wound care, concerns focussing on its role are bound to arise. These concerns, which centre on issues s...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.3710337281227112,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10246189",
          "text": "A dressing down for tariff system.. The poor standard of dressing provision in the crucial role of community nursing is discussed by Roy Lukacs, assistant district finance officer, Aylesbury and Milton Keynes Health District and Mike Dormer, produ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.35555732250213623,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7724638",
          "text": "Wound dressings on the Drug Tariff.. Nurses in the community need to be aware of the range of dressings available. Hospital nurses also need this knowledge to inform discharge planning.",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 185,
          "rerank_score": 0.33276131749153137,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/4680909",
          "text": "Special problems in the burn treatment of children with special reference to the use of a new dressing.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 103,
          "rerank_score": 0.33185234665870667,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11061705",
          "text": "Wound dressings reclassified by the FDA.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 40,
          "rerank_score": 0.3281148076057434,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7950536",
          "text": "Controlling the NHS drugs budget. Specialised dressings are not available to general practitioners.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 99,
          "rerank_score": 0.3147345185279846,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11010701",
          "text": "General and plastic surgery devices; classification of the nonresorbable gauze/sponge for external use, the hydrophilic wound dressing, the occlusive wound dressing, and the hydrogel wound dressing. Food and Drug Administration, HHS. Final rule.. ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.312411367893219,
          "rerank_position": 10
        }
      ],
      "id": "67cc9bef81b1027333000013",
      "type": "factoid",
      "body": "What is DRESS in the context of drug therapy?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/30512647",
        "http://www.ncbi.nlm.nih.gov/pubmed/25216633",
        "http://www.ncbi.nlm.nih.gov/pubmed/18374869",
        "http://www.ncbi.nlm.nih.gov/pubmed/18957877",
        "http://www.ncbi.nlm.nih.gov/pubmed/16913392",
        "http://www.ncbi.nlm.nih.gov/pubmed/17094994",
        "http://www.ncbi.nlm.nih.gov/pubmed/23299641",
        "http://www.ncbi.nlm.nih.gov/pubmed/25312733",
        "http://www.ncbi.nlm.nih.gov/pubmed/28152368",
        "http://www.ncbi.nlm.nih.gov/pubmed/12822204"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30512647",
          "text": "[Adverse effects of statins].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 29,
          "rerank_score": 0.9796808958053589,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25216633",
          "text": "Debate on adverse effects of statins.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 37,
          "rerank_score": 0.8643001317977905,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18374869",
          "text": "[Cutaneous adverse effects of statins].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 39,
          "rerank_score": 0.8389387130737305,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18957877",
          "text": "Safety of statins.. PURPOSE OF REVIEW: To examine the evidence for the adverse effects that have been reported during the use of statins. RECENT FINDINGS: We now have over twenty years of prescription use and many large well controlled trials with...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7922981977462769,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16913392",
          "text": "Safety issues with statin therapy.. OBJECTIVE: To describe the most important potential adverse effects related to statin therapy, discuss mechanisms of toxicity and drug interactions, and suggest approaches for enhancing safety with statin therap...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7611573934555054,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17094994",
          "text": "Statin-associated adverse effects beyond muscle and liver toxicity.. Randomized controlled trials with 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) have consistently demonstrated significant reductions in cardiova...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7606997489929199,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23299641",
          "text": "Do the frequencies of adverse events increase, decrease, or stay the same with long-term use of statins?. Statins are widely used for their cholesterol-lowering properties and proven reduction of cardiovascular disease risk. Many patients take sta...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7593139410018921,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25312733",
          "text": "Adverse effects of statins - myths and reality.. Statins reduce cardiovascular mortality and morbidity as well as cardiovascular events in patients with a very high risk of cardiovascular disease (CVD) and also in subjects with high or moderate ri...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7592158317565918,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28152368",
          "text": "[Safety of statins].. The discovery of statins, was a landmark in primary and secondary prevention of cardiovascular disease, where cholesterol plays a central pathophysiologic role. Currently there are 7 statins, which according to recent meta-an...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7531787157058716,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12822204",
          "text": "[Adverse effects of statins].. The safety of the hydroxymethyl glutaryl-coenzyme A reductase inhibitors (statins) has been called into question following the recent withdrawal from the market of one of the class, cerivastatin. The withdrawal of ce...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.734686017036438,
          "rerank_position": 10
        }
      ],
      "id": "67d430f918b1e36f2e00000f",
      "type": "list",
      "body": "Adverse effects of statins."
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/37551617",
        "http://www.ncbi.nlm.nih.gov/pubmed/38810731"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37551617",
          "text": "Comprehensive interrogation of gene lists from genome-scale cancer screens with oncoEnrichR.. Genome-scale screening experiments in cancer produce long lists of candidate genes that require extensive interpretation for biological insight and prior...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.29864946007728577,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38810731",
          "text": "Age-Related Clusters and Favorable Immune Phenotypes in Young Breast Cancer Patients.. Breast cancer (BC) patients aged <40 years at diagnosis experience aggressive disease and poorer survival compared with women diagnosed with BC at 40 to 49 year...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": -0.028439689427614212,
          "rerank_position": 2
        }
      ],
      "id": "67d3460218b1e36f2e000004",
      "type": "summary",
      "body": "Describe oncoEnrichR"
    }
  ]
}